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Key Messages 
- This systematic review and meta-analysis found increased mortality and morbidity for 
some health outcomes in the medium and long term, particularly: (i) increased mortality 
rates for all causes, myocardial infarction, and stroke, and (ii) greater mean levels of 
glycated haemoglobin  
- However, this review also found no evidence of earthquake effects in terms of blood 
pressure, body mass index, and lipid biomarkers 
- Epidemiological surveillance after all major earthquakes is essential to set up public health 
priorities and advance research 
- Whenever possible, future studies should use a cohort design, include both temporal and 
geographical comparison groups, and assess both physical and mental health indicators 
- Post-earthquake epidemiological surveillance should also capture the impact of seismic 
events on the access and utilization of healthcare services 
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Abstract 
Background. Accurate monitoring of population health is essential to ensure proper recovery 
after earthquakes. We aimed to summarize the findings and features of post-earthquake 
epidemiological studies conducted in high-income countries and prompt the development of 
future surveillance plans. 
Methods. Medline, Scopus, and 6 sources of grey literature were systematically searched. 
Inclusion criteria comprised: observational study conducted in high-income countries with at least 
one comparison group of unexposed participants, measurement of health outcomes at least one 
month after the earthquake. 
Results. Fifty-two articles were included, assessing the effects of 13 earthquakes occurred in eight 
countries. Most studies had a time-series (33%) or cross-sectional (29%) design, included 
temporal comparison groups (63%), used routine data (58%) and focused on patient subgroups 
rather than the whole population (65%). Individuals exposed to earthquakes presented: 2% higher 
all-cause mortality rates (95% confidence interval [CI] 1 to 3%), 36% (95%CI 19 to 57%) and 
37% (95%CI 29 to 46%) greater mortality rates from myocardial infarction and stroke, 0.16 higher 
mean percent points of glycated haemoglobin (95%CI 0.07 to 0.25 percent points) and no evidence 
of earthquake effects for blood pressure, body mass index, and lipid biomarkers. 
Conclusion. A more regular and coordinated use of large and routinely-collected datasets would 
benefit post-earthquake epidemiological surveillance. Whenever possible, a cohort design with 
geographical and temporal comparison groups should be used, and both communicable and non-
communicable diseases should be assessed. Post-earthquake epidemiological surveillance should 
also capture the impact of seismic events on the access and utilization of healthcare services.
Introduction 
Over the last decades, the frequency of natural disasters has risen sharply leading to dramatic 
consequences and huge economic losses. Only in 2014, 324 natural disasters were reported, 
resulting in 141 million casualties and in damages for nearly 100 billion dollars.1 Geophysical 
disasters, including earthquakes, accounted for circa 10% of these events. 
The Sendai Framework for Disaster Risk Reduction promoted by the United Nations fosters a 
comprehensive approach for disaster prevention, response and recovery, and therefore represents 
an important step forward to reduce disaster-induced mortality and morbidity. As such, the Sendai 
Framework highlights that an accurate monitoring of the health status of populations exposed to 
disasters is essential to identify priority interventions and restore previous health condition.1,2 
Given that earthquakes are non-predictable events, epidemiological surveillance is particularly 
useful to alleviate the burden of death, disability and disease that often follow these calamities. 
Noteworthy is that low-income countries are the most affected by disasters. Regrettably, more 
pressing political and economic constraints make long-term epidemiological surveillance often 
impracticable in these settings. By contrast, high-income countries rely on more robust healthcare 
networks which should allow for the conduction of long-term epidemiological research. However, 
epidemiological follow-up after earthquakes seems to be often scant and poorly planned also in 
countries with well-established healthcare systems.3–5 
Although several approaches for proper epidemiological monitoring after earthquakes have been 
discussed,1,6 a comprehensive overview of earthquake-related health effects in the medium or long 
term is not yet available as most previous studies focused on the immediate health effects of these 
calamities (i.e., in terms of hours or days).7,8 Reviews reporting on medium and long-term 
earthquake effects either focused on specific earthquakes9,10 or specific sets of health outcomes—
particularly in the field of mental health.11,12 
To our knowledge, no comprehensive systematic research has been conducted on all medium and 
long-term health effects of earthquakes to date. This study aimed to fill this gap by providing an 
insight on the methodological approaches and main findings of epidemiological studies assessing 
the middle and long-term effects of earthquakes in high-income countries. 
 
Methods 
We carried out this systematic review and meta-analysis in accordance with the Preferred 
Reporting Items for Systematic review and Meta-Analysis (PRISMA) statement.13 
Search and selection 
We searched two electronic databases, Pubmed (MEDLINE) and Scopus, and 6 sources of grey 
literature including the websites of The World Health Organization, Centers for Disease Control 
and Prevention – USA, European Centre for Disease Control and Prevention – European Union, 
National Institutes of Health – USA, EpiCentro Istituto Superiore di Sanità – Italy and Centro di 
documentazione per la promozione della salute – Italy). Supplementary Materials 1 lists the 
search strings used. We included all studies concerning humans and written in either of the 
following 6 languages: English, Italian, Spanish, French, Portuguese, German. No time 
restrictions were set. All the reviews found with this search were manually inspected in order to 
obtain additional studies. 
Four authors (ARG, BP, EA, MA) independently screened the titles and abstracts of all papers to 
exclude those not relevant to the objective of the review; any disagreement was resolved through 
discussion among these authors. One author (among ARG, DS, GI, MA) read the full-texts of the 
papers that passed the initial screening to assess compliance with the predefined inclusion and 
exclusion criteria, and their work was checked independently by another author (either BP or EA). 
Inclusion and exclusion criteria 
We included studies that: (i) focused on health indicators14,15 such as mortality and disease 
incidence, prevalence of risk factors, and access and utilization of healthcare services; (ii) 
measured indicators occurred at least one month after the main seismic event; (iii) investigated an 
earthquake that took place in a country classified as a high-income economy by the World Bank;16 
(iv) had an observational design with at least one comparison group, including either a 
measurement done before the earthquake (from now on, ‘temporal comparison group’) or obtained 
from an area that was not affected by the earthquake (‘geographical comparison group’). 
Studies were excluded if: (i) the health effects of the earthquake could not be distinguished from 
those due to other natural disasters; (ii) some or all of the participants in the comparison group 
were exposed to the earthquake; (iii) exposure or outcome were not measured objectively (e.g., 
measurement of self-reported intensity of earthquake damage or use of self-reported pre-
earthquake heath status collected during a post-earthquake survey); (iv) the study did not report 
on quantitative research, was a literature review, or was retracted. 
For the specific case of the Great East Japan earthquake of 11 March 2011, which was followed 
by a tsunami that flooded the area located within 10 km from the coast17 and a nuclear accident 
that caused a mass evacuation of the area located in the radius of 20 Km from the Fukushima-
Daiichi nuclear power plant,18 we excluded studies regarding areas located ≤ 10 Km from the 
coast and ≤ 20 Km from the Fukushima-Daiichi power plant. 
Data extraction 
For each study, one author (among ARG, MA, DS, GI, BP, EA) extracted data from included 
papers using a predefined data extraction template and another author (either BP or EA) 
independently checked their work. Any disagreement was resolved by discussion. We extracted 
the following study-specific characteristics: earthquake investigated, study design (prospective or 
retrospective cohort, cross-sectional study, time-series study), study population, sample size, 
percent of male participants, mean participant age, data source (e.g., hospital records, ad-hoc 
databases, or both). For each outcome and comparison group, we extracted the following variables 
as appropriate: number of participants, start and end of follow-up, mean and variance (either 
standard deviation, standard error, or interquartile range; the latter two were converted to standard 
deviation as appropriate). Since most studies reported on more than one outcome, the total number 
of outcomes is greater than the total number of studies. We calculated person-years multiplying 
group-specific number of participants and length of follow-up. We extracted reported units for all 
continuous outcomes. In case of multiple publications on the same earthquake, we used the most 
up-to-date and comprehensive information. 
Data synthesis 
In descriptive analyses, we used frequencies and proportions to describe categorical variables, and 
medians and interquartile ranges to summarize continuous variables. 
We carried out meta-analyses for all the outcomes assessed. Before carrying out meta-analyses, 
we harmonised units for continuous outcomes, collapsed within-study subgroups, and dealt with 
multiple comparison groups as detailed in Supplementary Materials 2. For each outcome, 
within-study summary measures such as incidence rate ratio (IRR), risk ratio (RR), and mean 
difference (MD) were estimated as appropriate to compare exposed and unexposed participants, 
using the default settings of the metafor package in R.19 Outcome-specific summary estimates 
were then pooled if available for at least two studies having the same type of comparison group 
(either temporal of geographical) and the same type of summary measure (either IRR, RR, or 
MD). Owing to heterogeneity in study characteristics and earthquake assessed, we fitted random 
effects models. We tested evidence of heterogeneity with the Q statistic and quantified the 
percentage of variability in the effect estimates due to heterogeneity with the I-squared statistic. 
We plotted both study-specific and pooled effect estimates, including 95% confidence intervals, 
using Forest plots generated with the metafor package in R.19 For all meta-analyses including at 
least 4 studies, we conducted sensitivity analyses to check if the pooled estimates were robust to 
variations in the following study-level characteristics: maximum duration of follow-up, proportion 
of males, mean age, study design, and study population. All analysis tests were two-sided. 
 
Results 
Search and selection of studies 
Overall, we found 2,976 papers (1,549 from Pubmed/MEDLINE and Scopus, and 1,427 from the 
grey literature – Figure 1). The initial screening of titles and abstracts led to inclusion of 377 
papers. Fifty-two papers met the eligibility criteria and were included. Among the 325 papers 
excluded, 122 (38%) either focused on a different natural disaster or the earthquake effects could 
not be disentangled from those of other natural disasters, 84 (26%) lacked a non-overlapping 
comparison group, and 49 (15%) did not report on quantitative research (e.g., were case reports, 
commentary articles, letters, news articles, or editorials). 
[Figure 1 here] 
 
Earthquake characteristics 
Most studies were conducted in Japan (n=27) and Italy (n=13) (Table 1). The most investigated 
earthquakes, with 10 studies each, occurred in Kobe, (Japan, 17 January 1995), L’Aquila (Italy, 6 
April 2009), and Eastern Japan (11 March 2011). The median number of deaths was 143 
(interquartile range [IQR] 12 to 2342) and the median earthquake magnitude was 6.6 on the 
Richter scale (IQR 6.3 to 6.9). The countries that presented the largest cumulative number of 
deaths were Japan (n=26,467) and Italy (n=3,030). 
[Table 1 here] 
 
Study characteristics 
We extracted meta-analysis data from 52 studies including 82,479 subjects from studies which 
analysed individual-level data and 50,015,914 subjects from studies based on aggregated data, in 
which individual-participant characteristic were not available for the denominator. Table 2 
presents the main characteristics and outcomes assessed by the studies included in this review. 
[Table 2 here] 
 
Included studies were published between 1981 and 2015, mostly (58%) between 2010 and 2015. 
Most studies used time series (n=17) and cross sectional (n=15) study designs, and employed a 
temporal comparison group, i.e. the outcome of interest was measured at least twice, both before 
and after the earthquake (n=33). While most studies (n=34) selected participants based on their 
age or medical condition, 15 studies focused on the general population. Most studies used 
routinely collected data (n=30), e.g. data from hospital databases (n=18). A considerable number 
of studies (n=19) used ad-hoc data, mostly obtained from questionnaires (n=13). Only 7 out of 52 
studies evaluated whether the effects of earthquakes varied by the intensity of earthquake exposure 
(e.g., distance from the earthquake epicentre). 
Studies had a median sample size of 1,448 subjects (interquartile range [IQR] 175 to 372,253); 
the largest samples were collected in studies with a time-series design (median 417,900; IQR 
301,053 to 4,391,035) and having both temporal and geographical comparison groups (median 
163,992; IQR 742 – 845,617). The median number of measurements of was 3 (IQR 2 to 10); the 
highest number of measurements was observed in studies with a time-series design (median 
number of measurements 14; IQR 6 to 39) and in studies with temporal comparison group (median 
number of measurements 4; IQR 2 to 12). Overall, the median length of follow-up was 6 months 
(IQR 3 to 12); the median length of follow-up was longest for time-series studies (7 months; IRQ 
3 to 12) and for studies with both temporal and geographical comparison groups (20 months; IQR 
10 to 36). 
Earthquake effects on outcomes assessed by 4 or more studies 
While accounting for across study heterogeneity, there was strong evidence (p<0.001) of 36% 
greater mortality rates from myocardial infarction after earthquakes compared to measurements 
carried out before the earthquake (95% confidence interval [CI] 19% to 57%) (Figure 2A). In a 
meta-analysis of 4 studies, there was weak evidence (p=0.0725) of 11% lower suicide rates after 
the earthquakes (95%CI -21% to 1%). 
People exposed to earthquakes had higher mean levels of glycated haemoglobin (0.16 percent 
points, 95%CI 0.07 to 0.25) compared to people unexposed to the earthquake (Figure 2B). There 
was no evidence of earthquake effects in terms of blood pressure, body mass index, and lipid 
biomarkers. 
These findings were generally robust to a number of sensitivity analyses (Supplementary 
Materials 3), with the exception of suicide rates that were higher among people exposed to the 
earthquake in 1 study using a geographical comparison – an apparent contradiction with the 4 
studies using temporal controls. 
[Figure 2 here] 
 
Earthquake effects on outcomes assessed by 1 to 3 studies 
The full results of earthquake effects for all outcomes from all studies, including effects on several 
psychometric scales, are available in Supplementary Materials 4. In the interest of concision, 
Figure 3 presents only findings based on a sample size of at least 1,000 participants and with an 
effect p-value lower than 0.001. 
Although only two studies were available for each meta-analysis, all-cause mortality rates were 
2% higher (95%CI 1% to 3%) and stroke mortality rates were 37% higher (95%CI 29% to 46%) 
among individuals exposed to earthquakes compared to unexposed participants (Figure 3A).  
In 4 individual studies that could not be pooled together owing to incompatible outcome and 
comparison-group definitions, individuals exposed to earthquakes had generally higher mortality 
rates from cardiovascular disease (Supplementary Materials 4). 
Among people exposed to the Kobe earthquake (Japan, 1995), there was evidence of a general 
increase in incidence rates of both total and bleeding gastric ulcers. 
People exposed to the Irpinia and Naples earthquake (Italy, 1980) had (i) lower incidence rates of 
German measles and whooping cough, (ii) higher incidence rates of typhoid/paratyphoid and viral 
hepatitis infections, and (iii) 3% lower hospital discharge rates (95%CI -3% to -2%). 
After the L’Aquila earthquake (2009, Italy), there was evidence of a 6% increase in overall 
antipsychotics consumption (95%CI 4% to 8%), particularly promazine and amilsulpride. 
Earthquake effects for antidepressants were in different directions. There was evidence of a 2% 
increase in serotonin reuptake inhibitors consumption rates (95%CI 1% to 2%), but also evidence 
of a 5% reduction in tricyclics (95%CI -6% to -4%) and a 1% reduction in other antidepressants 
(95%CI -2% to -1%). 
People exposed to L’Aquila earthquake also had a two-fold greater risk of sedentary behaviour 
(95%CI 1.56 to 2.60) (Figure 3B). 
After the Great East Japan 2011 earthquake, there was evidence of 0.95 percent point greater 
average daily prevalence of insomnia compared to daily measurements recorded before the 
earthquake (95% 0.93 to 0.98 percent points) (Figure 3C). 
 [Figure 3 here] 
 
 Discussion 
The steep rise in the world population over the past decades and the urbanization of zones with 
high seismic risk have played a key role in amplifying the impact of earthquakes on human 
health.20 Unfortunately, this risk has not triggered a simultaneous improvement of epidemiological 
surveillance plans in the aftermath of earthquakes. For this reason, a review of the epidemiological 
studies investigating the chronic health effects of earthquakes can be helpful to guide the 
development and implementation of future surveillance guidelines. 
Discussion of the methodological approaches of the studies included 
Out of the 50 seismic events with magnitude ≥ 6.0 that occurred in high-income countries between 
1990 and 2012,21 only 11 were investigated by the studies included in this review 
(Supplementary Materials 5). These 11 events caused a median of 143 deaths (IQR 26 to 421), 
while the 39 events that were not investigated resulted in a median of 2 deaths (IQR 1 to 7) despite 
having similar magnitude (6.7 vs 6.6, respectively). This suggests that the studies meeting the 
inclusion criteria for this review focused mostly on the earthquakes that caused the highest number 
of casualties. The fact that the earthquakes of Great East Japan (20,896 deaths), Kobe/Hanshin-
Awaji (5,530) and L'Aquila (295) were the most frequently investigated supports this hypothesis. 
However, other deadly seismic events were apparently not investigated, such as the earthquakes 
of Hokkaido (Japan 1993, 243 deaths) and Georgia (29th April 1991, 114 deaths). Since most of 
the studies included in this review were published after the year 2000 and the number of studies 
increased exponentially over time, it is possible that some earthquakes were not investigated either 
because, at that time, the monitoring of the chronic effects of earthquakes was not deemed a public 
health priority, or because the epidemiological studies conducted were never published or made 
available in the institutional websites that we inspected. 
The principal reason for exclusion from this review was the difficulty in disentangling the effects 
of earthquakes from those of other natural disasters occurred simultaneously or as a consequence 
of the main seismic event (e.g. the Great East Japan earthquake in March 2011 which was followed 
by a tsunami and a nuclear accident). These studies were excluded based on the assumption that 
different types of disasters may result in different types of health effects.22 For example, an 
isolated nuclear accident can cause immediate mental stress merely on anticipatory basis (fear of 
cancer, congenital anomalies, etc.) with a greater impact on adult age subgroups (capable of 
recognizing the risk). By contrast, people exposed to earthquakes appear more likely to suffer 
from post-traumatic stress disorder, rather than from anticipatory mental stress.23 Therefore, we 
excluded a considerable number of studies in order to be able to specifically assess the 
epidemiological effects of earthquakes. 
Most studies used a cross-sectional or time-series design (33% each) and included temporal 
comparison groups (63%); prospective cohorts were only used in 14 studies (27%). It is well-
known that longitudinal studies have a more robust design than cross-sectional studies, enabling 
the investigation of causal hypotheses when using appropriate methods. However, cohort studies 
can be resource-consuming, whereas cross-sectional studies with a temporal or geographical 
comparison group are generally cheaper and can provide timely estimates if a quick response is 
needed.24 Since timeliness is usually not a priority for studies assessing medium and long-term 
health effects, it is possible that the availability of resources may have influenced the choice of 
the cross-sectional design over the cohort design for some studies. 
Furthermore, data sources and their accessibility play an important role in influencing the choice 
of many study characteristics such as the outcome under study, study design, and timeliness of the 
investigation. The majority of the studies (58%) used routinely collected data, especially hospital 
databases (37%). Interestingly, in several studies investigating L’Aquila earthquake (Italy, 2009) 
there was a lower utilization of routine data compared to studies concerning other earthquakes in 
high-income countries.25 The type of outcomes investigated and the study design applied might 
have been influenced by context-specific factors, namely availability of appropriate resources, 
human capital, and data sources. A nationally-coordinated and interdisciplinary approach could 
overcome these limitations by involving epidemiologists and health professionals from both the 
area hit by the earthquakes and from other centres specialized in disaster epidemiology. 
In the case of unpredictable exposures such as some natural disasters, routine data with proper 
temporal and geographical coverage can provide a good compromise between methodological 
rigour and economic sustainability. As high-quality routine data are available in many affluent 
countries, a more widespread linkage between routinely-collected data sources (e.g. primary care 
records, specialist registries, hospital admission records, mortality registries) would enable 
systematic assessment of the effects of earthquakes on the most relevant health outcomes while 
accounting for the most common sources of bias and confounding. 
Discussion of the main earthquake effects captured by the studies included 
The studies included in this review measured several outcomes comprising: mortality, 
cardiovascular diseases, mental health and problems related to lifestyle (Figures 2-3, 
Supplementary Materials 3-4). Some evidence of a post-earthquake increase was observed for 
many of these outcomes, suggesting that the long-term assessment of the population’s health status 
is essential to set priorities in resource allocation. Interestingly, in their review on the public health 
effects of mass traumatic events, Johnson et al. mentioned motor disability and musculoskeletal 
sequelae as chief chronic earthquake-related health problems.22 On the contrary, our findings 
suggest that a wide range of physical and mental health endpoints should be monitored several 
months or years after an earthquake. 
This systematic review and meta-analysis found an increased mortality rate for all causes, 
myocardial infarction, and stroke from the first month to up to 3 years after an earthquake. While 
these findings have been consistently reproduced in the literature, the reasons at their basis are 
still unclear. Previous research has underscored the importance of psychological stress as a 
predictor of coronary heart disease 26,27; therefore, it is possible that psychological stress and the 
subsequent sympathetic activation may have played a role in explaining this association. However, 
a meta-analysis of 7 studies included in this paper showed that earthquakes do not seem to affect 
clinically measured blood pressure. Additional factors explaining these findings include the 
destruction of medical records which can lead to one or more consultations/treatments missed, the 
occurrence of circumstances that can delay self-care such as relocation and unemployment, and 
reporting bias as some outcomes may have been considered less interesting by researchers and 
journals. 
Regarding the metabolic effects of earthquakes, previous reviews pointed to higher rates of 
diabetes among disaster-exposed individuals.22,28 Our meta-analysis confirms that a modest 
increase of glycated haemoglobin occurs from two to twelve months after earthquakes. Previous 
literature suggests that at the basis of this phenomenon there could be a combination of various 
factors such as the disruption of normal routines, emotional stress, change in dietary intake, 
difficult access to supplies due to the damage of health facilities and pharmacies or interruption 
in the mobilization of stockpiles to long-term established shelters. 
Studies reporting on the rates of bleeding and non-bleeding gastric ulcers highlighted an increased 
probability of these events in the long-term among individuals exposed to earthquakes. 
Interestingly, this was true regardless of the temporal or geographical nature of the comparison 
group. This could be attributed to the loss of function of hospitals located in the hardest-hit areas, 
failure to follow up patients with mild symptoms and mental stress. Of note, the negative impact 
of the earthquake on the functioning of those health facilities located in the proximity of the 
epicentre determined, such as in the study by Aoyama et al,29 a lower number of diagnostic 
procedures performed; this may have masked an even greater incidence of gastrointestinal ulcer 
in the areas most affected by earthquakes. 
Limited evidence for infectious epidemics after geophysical disasters is available;30 our results 
suggest that gastrointestinal infectious agents could be more easily spread in the aftermath of 
earthquakes while, conversely, airborne infections might decrease. These data are in contradiction 
with current literature22 and might be due to the fact that this meta-analysis included only one 
paper focusing on infectious diseases and that it was restricted to a single country (Italy). Further 
studies would be useful to appreciate long-term earthquake-related patterns of infectious diseases 
in high-income countries. 
In light of our findings, the role that earthquakes may play in mental health also deserves special 
attention. While earthquakes seemed to protect from suicide when temporal comparison groups 
were used, the opposite was found when the comparison group was geographical and when 
assessing both suicidal ideation and suicide attempts (Supplementary Materials 3-4). This 
highlights the complexity of this phenomenon, which might be heavily influenced by both 
individual and socio-contextual factors such as gender, earthquake-related experience (e.g. injury, 
clean-up work activity, loss of family members), sociocultural factors and pre-earthquake mental 
health. Some studies reported an increase in a vast array of psychiatric and mood disorders, 
especially in the case of repeated or high-intensity exposure to earthquakes.31,32 This suggests that 
earthquakes may be a serious risk factor for mental health disease due to, firstly, the traumatic 
environmental experience and secondly, the life changes that follow the initial event (e.g. loss of 
family and friends, unemployment and/or relocation). Unfortunately, differences in terms of 
outcome definitions and comparison groups prevented further analysis. Altogether, our findings 
make the case for additional and larger studies including both geographical and temporal 
comparison groups. 
Lastly, it is worth noting that four studies included in our review focussed on health outcomes 
after the sequence of 4 earthquakes occurred in Christchurch (New Zealand, September 2010-
mid-2012).34–37 Owing to the small numbers of studies available, it is difficult to compare the 
health effects of repeated events with those of a single earthquake. However, taken together, the 
effects reported by these studies seem to be broadly in line with those found by investigations 
concerning a single event (e.g., greater prevalence of mental health disorders among people 
exposed to multiple seismic events compared to unexposed individuals). 
Limitations of this review 
Papers written in Japanese were excluded from this review; therefore, some relevant studies may 
have been missed out. However, this looks unlikely as the most relevant Japanese studies were 
probably published in English, and our search of six sources of grey literature seems sufficiently 
broad to capture the most influential epidemiological studies carried out in Japan. 
Only two electronic databases (Medline and Scopus) were used in this review. Considering the 
number and combination of keywords used in this search it would have been unfeasible, with the 
resources available, to extend the search to other databases. However, these two databases are 
among the most comprehensive for epidemiological literature. Additionally, grey literature search 
is likely to have detected initially unretrieved articles. 
Some heterogeneity was noted in the meta-analyses we carried out. This is understandable owing 
to the breadth of our review. Although we attempted to combine studies that were as comparable 
as possible, this review includes studies conducted in different times, places, and with varying 
methodology. Between-study heterogeneity was therefore explicitly accounted for, and random-
effects meta-analyses were used for all outcomes reported by at least two comparable studies. 
It is worth noting that the present review focuses on the studies assessing the independent effects 
of an earthquake or a series of seismic events. Therefore, the findings of this review should not be 
generalised to other natural disasters occurring simultaneously with earthquakes or caused by 
them. 
Lastly, this meta-analysis was restricted to earthquakes occurred in high-income countries due to 
the political and economic barriers that render long-term epidemiological surveillance often 
impracticable in these settings. While this limitation may be overcome in future updates of this 
review, it is worth noting that caution should be used when generalised the findings of this review 
to low-income countries. 
Suggestions for the epidemiological surveillance of future earthquakes 
From the evidence accrued in the epidemiological studies carried out in the past thirty years, some 
suggestions emerge that could inform future studies aiming to assess the medium and long-term 
health effects of earthquakes: 
1. Aim: every major earthquake should be investigated for its medium and long-term health 
effects. In the past, these effects have not been assessed as extensively as for other types 
of environmental exposure. The numerous health effects reported in the present review 
suggest that the health needs arising from earthquakes may have been underestimated in 
many cases, even in high-income countries. Future epidemiological surveillance should 
be set up to enable timely and in-depth measurement of the medium and long-term health 
effects of every earthquake. 
2. Study design: (a) an intensive and coordinated use of routine data can benefit both 
epidemiological surveillance and etiological studies in the aftermath of earthquakes; (b) 
both geographical and temporal comparison groups should be included and both the 
general population and vulnerable groups (e.g., children and the elderly, patients with 
chronic disease, healthcare workers involved in the earthquake response) should be 
considered; (c) a cohort study designs should be preferred whenever possible. 
3. Indicators: the complexity in the results obtained in this meta-analysis should prompt 
epidemiological surveillance studies to capture and report the changes of as many health 
indicators as possible, e.g. mortality, mental health, vital signs, biomarkers, behavioural 
risk factors, and health service utilization. This amount of information will be instrumental 
to guide practice, by improving efficiency and efficacy of evidence-based public health 
interventions, and research, by helping to uncover long-term earthquake effects that have 
not yet been detected. 
4. Contributors: a multidisciplinary approach should be preferred, starting from the 
identification of priority indicators. Contributors should encompass professionals from 
different and complementary disciplines, including epidemiologists, statisticians, and 
public health professionals capable of devising and processing standardized protocols for 
data collection and analysis. The involvement of professionals from various disciplines 
would also ensure effective communication of key messages to the population at risk, 
which is also a priority in both recovery and preparedness phases.38 
 
  
Conclusion 
Despite the efforts and resources involved to prevent and mitigate the effects of earthquakes, these 
disasters have still a tremendous health impact even in high-income countries. The Sendai 
Framework for Disaster Risk Reduction, adopted at the Third United Nations World Conference 
(Sendai, Japan, March 2015), pursues to achieve a “substantial reduction of disaster risk and 
losses in lives, livelihoods and health”2. In order to meet this goal, appropriate preparedness, 
response and damage mitigation are essential when facing unpredictable events, as in the case of 
earthquakes.39 
Epidemiology can play a major role in fostering recovery and preparedness. Considering the 
numerous earthquake-related health effects reported in this review, all future earthquakes should 
be investigated to capture their medium and long-term health effects. As earthquakes have been 
associated to a broad range of health outcomes, rigorous monitoring of their chronic health effects 
is pivotal to prioritize local and national public health interventions. Allocation of resources 
matching the health needs of the population affected by the earthquake can alleviate the chronic 
health effects of these disastrous events. Additionally, regular updates on the health status of the 
populations would improve future preparedness plans. Already in 1985, De Bruycker and 
colleagues pointed out “the need to establish, in each disaster-prone area, a health evaluation 
system [..] through which data could be collected in view of improving the preparedness and self-
reliance of the stricken community itself”.40 
Over the past 30 years, epidemiology has benefited from great technological advances in many 
countries, including improvement in computation capabilities and availability of large and 
integrated electronic datasets. These advances now render feasible planning of epidemiological 
surveillance capable of providing regular updates on a population’s health status in the medium 
and long-term. We trust that the experience accrued in the past three decades on the epidemiology 
of earthquakes, and summarized in the present paper, may serve to inform further steps to endure 
promotion of the population’s health in the aftermath of earthquakes. 
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Table 1. Characteristics of the 13 earthquakes investigated by the 52 studies included in this review 
Country Date Earthquake Magnitudea N deathsa N studies 
Australia 28 December 1989 Newcastle 5.4b 12b 1 
Chile 13 June 2005 Tarapacá 7.8 11 1 
 27 February 2010 Maule region 8.8 547 1 
Greece 7 September 1999 Athens and Ano Liosia 6.0 143 2 
Iceland 17 June 2000 Holt 6.6 0 1 
Italy 23 November 1980 Irpinia and Naples 6.5c 2,735c 3 
 6 April 2009 L’Aquila 6.3 295 10 
Japan 17 January 1995 Kobe and Hanshin-Awaji 6.9 5,530 10 
 23 October 2004 Niigata Prefecture 6.6 40 6 
 25 March 2007 Noto Peninsula 6.7 1 1 
 11 March 2011 Great East Japan (Higashi-Nihon) 9.0 20,896 10 
New 
Zealand 
22 February 2011d Christchurch 6.1 181 5 
USA 17 January 1994 Los Angeles / Northridge, California 6.7 60 1 
 
a Except where specified otherwise, magnitude and number of deaths are obtained from the United States Geological Survey 
1990-2012 archive 21 
b Source: National Centers for Environmental Information 41 
c Source: United States Geological Survey archive of the earthquakes with >1,000 fatalities 1900-2014 42 
d One study focused on shocks occurred on 4 September 2010; four on shocks occurred both in 2010 and 2011 (22 February, 13 
June, 23 December)
Table 2. Main characteristics and outcomes assessed by the 52 studies included in the review 
Study Earthquake (Year) 
Study Design 
(Comparison) 
Mean  
Age 
(years
) 
%  
Male
s 
Follow-
up 
(months) 
N  
Participant
s 
Mortality 
Disease 
Pharmacology 
Vital signs & 
biomarkers 
Lifestyle & 
preventio, 
screening, 
healthcare 
utilization 
Psychomet
ric scales 
Other 
outcomes 
Circulator
y 
Nervou
s 
system 
Mental 
health 
Infectiou
s 
Digestive 
Pregnancy, 
childbirth and 
puerperium 
Endocrine 
Alexander 1982 43 Irpinia & Naples (1980), Italy Time-series (T) - - 7 6,033,296 - - -   - - - - -  - - 
Aoki 2012 44 Great East Japan (2011) Time-series (T) - - 6 4,391,035 - - -  - - - - - - - - - 
Aoyama 1998 29 Kobe (1995), Japan Cross sectional (GT) - - 2 26,931 - - - - -  - - - - - - - 
Azuma 2010 45 Niigata (2004), Japan Cohort (T) 41 71 14 4,035 -  - - - - - - -  - - - 
Bodvarsdottir & Elklit 2004 46 Iceland (2000) Cross sectional (G) 42 47 3 81 - - -  - - - - - - -  - 
Bourque 2002 47 Los Angeles (1994), USA Time-series (T) - - 12 7,676,512 - - -  - - - - - - - - - 
Chan 2013 34 
Christchurch (2010-2011), New 
Zealand 
Time-series (T) - - 1 372,253 -  - - - - - - - - - - - 
D'Argenio 2013 48 L'Aquila (2009), Italy Cross sectional (T) 50 50 19 1,240 - - -  - - - - -   -  
Dobson 1991 49 Newcastle (1989), Australia Time-series (T) - - 4 417,900   - - - - - - - - - - - 
Fergusson 2014 35 
Christchurch (2010-2011), New 
Zealand 
Cohort (G) 35 - 24 952 - - -  - - - - - -  - - 
Fujihara 2012 50 Great East Japan (2011) Cohort (T) 65 63 3 320 -  - - - - - - -  - - - 
Fukuda 1998 51 Kobe (1995), Japan Time-series (T) - - 9 5,395,158 - - - - - -  - - - - - - 
Hata 2012 52 Great East Japan (2011) Cohort (T) 66 100 2 5 -  - - - - - - - - - - - 
Hyodo 2010 53 Niigata (2004), Japan Time-series (GT) - 48 36 2,426,359 - - -  - - - - - - - - - 
Inui 1998 54 Kobe (1995), Japan Cohort (GT) 59 52 2 434 - - - - - - - - -  -  - 
Ishii 2014 55 Great East Japan (2011) Cohort (T) 41 6 4 16 - - -  - - - - - - - - - 
ISS 1981 56 Irpinia & Naples (1980), Italy Time-series (T) - - 3 1,212,387  - - - - - - - - - - - - 
Kamoi 2006a 57 Niigata (2004), Japan Cohort (T) 67 75 6 222 -   - - - -    - - - 
Kamoi 2006b 58 Niigata (2004), Japan Cohort (T) 59 42 12 65 -  - - - - -    - - - 
Kamoi 2006c 59 Niigata (2004), Japan Cohort (T) 49 16 2 352 - - - - - - - -   - - - 
Kannis-Dymand 2015 60 
Christchurch (2010), New 
Zealand 
Cross sectional (G) 46 - 2 345 - - -  - - - - - - -  - 
Kario 2001 61 Kobe (1995), Japan Cohort (T) 69 34 2 124 -  - - - - - - - - - - - 
Kario and Ohashi 1997 62 Kobe (1995), Japan Time-series (T) - - 3 64,082   - - - - - - - - - - - 
Kato 2014 63 Great East Japan (2011) Cross sectional (T) 41 33 6 600,000 - - -  - - - - - - - - - 
Kolaitis 2003 64 Athens (1999), Greece Cross sectional (G) 11 47 6 163 - - -  - - - - - - -  - 
Kotozaki 2012 65 Great East Japan (2011) Cohort (T) 21 50 3 30 - - - - - - - - -  -   
Nakagawa 2009 66 Niigata (2004), Japan Cross sectional (GT) - - 36 2,426,359  - - - - - - - - - - - - 
Nakano 2012 67 Great East Japan (2011) Cohort (T) 56 71 6 170 -  - - - - - - - - - - - 
Nishio 2009 68 Kobe (1995), Japan Time-series (T) - - 36 1,273,333 - - -  - - - - - - - - - 
Pearson 2013 37 
Christchurch (2010-2011), New 
Zealand 
Time-series (T) - - 16 372,253 - - - -  - - - - - - - - 
Pollice 2012 69 L'Aquila (2009), Italy Cohort (T) 32 62 3 117 - - - - - - - - - - -  - 
Rossi 2012 70 L'Aquila (2009), Italy Cross sectional (T) 18 42 10 1,476 - - - - - - - - - - -  - 
Roussos 2005 71 Athens (1999), Greece Cross sectional (G) - 44 3 1,937 - - - - - - - - - - -  - 
Sofia 2012 72 L'Aquila (2009), Italy Cross sectional (T) 75 52 4 102,669 -  - - - - - - - - - - - 
Sokejima 2004 31 Kobe (1995), Japan Time-series (T) - 45 24 17,651 - -  - - - - - - - - - - 
Stratta 2012 73 L'Aquila (2009), Italy Cross sectional (G) 33 44 12 948 - - -  - - - - - - -  - 
Sugiura 2013 74 Great East Japan (2011) Time-series (T) - 50 2 10,106 - - -  - - - - - - - - - 
Takegami 2015 75 
Great East Japan (2011); Kobe 
(1995), Japan 
Time-series (T) - - 12 16,545,012  - - - - - - - - - - - - 
Tanaka 2014 76 Great East Japan (2011) Cohort (T) 66 80 2 25 -  - - - - - -   - - - 
Tani 2014 77 Great East Japan (2011) Cohort (T) 67 52 2 205 -  - - - - - - -  - - - 
Tempesta 2013 32 L'Aquila (2009), Italy Cross sectional (GT) - 50 24 1,419 - - - - - - - - - - -  - 
Torche and Kleinhaus 2012 78 Chile (2005), Chile Cohort (GT) - 0 9 7,035 - - - - - -  - - - - - - 
Study Earthquake (Year) 
Study Design 
(Comparison) 
Mean  
Age 
(years
) 
%  
Male
s 
Follow-
up 
(months) 
N  
Participant
s 
Mortality 
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Pharmacology 
Vital signs & 
biomarkers 
Lifestyle & 
preventio, 
screening, 
healthcare 
utilization 
Psychomet
ric scales 
Other 
outcomes 
Circulator
y 
Nervou
s 
system 
Mental 
health 
Infectiou
s 
Digestive 
Pregnancy, 
childbirth and 
puerperium 
Endocrine 
Trevisan 1992 79 Irpinia & Naples (1980), Italy Cohort (T) 41 100 79 505 -  - - - - - - -  - - - 
Trifirò 2013 80 L'Aquila (2009), Italy Time-series (T) - - 11 301,053 - - - - - - - -  - - - - 
Tsuchida 2009 81 
Japan Noto Peninsula (2007), 
Japan 
Time-series (T) - - 1 34,000 -   - - - - - - - - - - 
Valenti 2012a 82 L'Aquila (2009), Italy Cohort (GT) - - 12 36 - - - - - - - - - - -  - 
Valenti 2012b 83 L'Aquila (2009), Italy Cohort (T) - 49 11 179 - - - - - - - - - - -  - 
Valenti 2014 84 L'Aquila (2009), Italy Cohort (GT) - 11 24 64 - - - - - - - - - - -  - 
Wu 2014 36 
Christchurch (2010-2011), New 
Zealand 
Time-series (T) - - 1 372,253 -   - - - - - - - - - - 
Yamamoto 1997 85 Kobe (1995), Japan Cross sectional (T) - 53 6 221 - - - - - - - - - - - -  
Yashiro 2000 86 Kobe (1995), Japan Cross sectional (G) 67 63 36 30  - - - - - - -   - -  
Zubizarreta 2013 87 Chile (2010), Chile Cross sectional (T) 48 33 4 5,040 - - - - - - - - - - -  - 
 
Comparison groups: T, temporal; G, geographical; GT, geographical and temporal 
ISS is the Italian National Institute of Health (Istituto Superiore di Sanità)
  
WHO, World Health Organization. CDC, Centers for Disease Control and Prevention (USA).  ECDC, 
European Centre for Disease Control and Prevention (EU). NIH, National Institutes of Health (USA). 
EpiCentro, Istituto superiore di sanità (Italy). DoRS, Centro di documentazione per la promozione della 
salute (Italy).   
  
Figure 2. Earthquake effects for all outcomes assessed by 4 or more independent studies  
 
HDL is high-density lipoprotein. I² is percentage of variation across studies due to heterogeneity. Follow-
up refers to the latest post-earthquake measurement.  
  
Figure 3. Earthquake effects for outcomes assessed by 1-3 studies based on at least 1,000 participants 
and with effect p-value < 0.001a 
 
 
a Sample size and p-value thresholds were set in the interest of concision. The full results are available in 
Supplementary Materials 4. 
I² is percentage of variation across studies due to heterogeneity. Follow-up refers to the latest post-
earthquake measurement.  
Supplementary Materials 1. Search strings 
 
Pubmed (MEDLINE) 
(Earthquakes[Mesh] OR earthquake*[Title/Abstract] OR quake*[Title/Abstract] OR seismic 
upheaval*[Title/Abstract] OR seism*[Title/Abstract] OR aftershock*[Title/Abstract]) AND 
("Andorra"[Title/Abstract] OR "Antigua and Barbuda"[Title/Abstract] OR 
"Antigua"[Title/Abstract] OR "Barbuda"[Title/Abstract] OR "Aruba"[Title/Abstract] OR 
"Australia"[Title/Abstract] OR "Austria"[Title/Abstract] OR "Bahamas"[Title/Abstract] OR 
"Bahrain"[Title/Abstract] OR "Barbados"[Title/Abstract] OR "Belgium"[Title/Abstract] OR 
"Bermuda"[Title/Abstract] OR "Brunei"[Title/Abstract] OR "Brunei 
Darussalam"[Title/Abstract] OR "Canada"[Title/Abstract] OR "Cayman 
Islands"[Title/Abstract] OR "Cayman"[Title/Abstract] OR "Channel Islands"[Title/Abstract] 
OR "Chile"[Title/Abstract] OR "Croatia"[Title/Abstract] OR "Curaçao"[Title/Abstract] OR 
"Cyprus"[Title/Abstract] OR "Czech Republic"[Title/Abstract] OR "Denmark"[Title/Abstract] 
OR "Equatorial Guinea"[Title/Abstract] OR "Estonia"[Title/Abstract] OR "Faeroe 
Islands"[Title/Abstract] OR "Finland"[Title/Abstract] OR "France"[Title/Abstract] OR 
"Polynesia"[Title/Abstract] OR "French Polynesia"[Title/Abstract] OR 
"Germany"[Title/Abstract] OR "Greece"[Title/Abstract] OR "Greenland"[Title/Abstract] OR 
"Guam"[Title/Abstract] OR "Hong Kong SAR, China"[Title/Abstract] OR "Hong 
Kong"[Title/Abstract] OR "Iceland"[Title/Abstract] OR "Ireland"[Title/Abstract] OR "Isle 
of Man"[Title/Abstract] OR "Israel"[Title/Abstract] OR "Italy"[Title/Abstract] OR 
"Japan"[Title/Abstract] OR "Korea, Rep."[Title/Abstract] OR "Korea"[Title/Abstract] OR 
"Kuwait"[Title/Abstract] OR "Latvia"[Title/Abstract] OR "Liechtenstein"[Title/Abstract] OR 
"Lithuania"[Title/Abstract] OR "Luxembourg"[Title/Abstract] OR "Macao SAR, 
China"[Title/Abstract] OR "Macao"[Title/Abstract] OR "Malta"[Title/Abstract] OR 
"Monaco"[Title/Abstract] OR "Netherlands"[Title/Abstract] OR "New 
Caledonia"[Title/Abstract] OR "New Zealand"[Title/Abstract] OR "Northern Mariana 
Islands"[Title/Abstract] OR "Norway"[Title/Abstract] OR "Oman"[Title/Abstract] OR 
"Poland"[Title/Abstract] OR "Portugal"[Title/Abstract] OR "Puerto Rico"[Title/Abstract] OR 
"Qatar"[Title/Abstract] OR "Republic"[Title/Abstract] OR "Russian 
Federation"[Title/Abstract] OR "Russia"[Title/Abstract] OR "San Marino"[Title/Abstract] OR 
"Saudi Arabia"[Title/Abstract] OR "Singapore"[Title/Abstract] OR "Sint 
Maarten"[Title/Abstract] OR "Slovak"[Title/Abstract] OR "Slovenia"[Title/Abstract] OR 
"Spain"[Title/Abstract] OR "St. Kitts and Nevis"[Title/Abstract] OR "St. 
Martin"[Title/Abstract] OR "Sweden"[Title/Abstract] OR "Switzerland"[Title/Abstract] OR 
"Trinidad and Tobago"[Title/Abstract] OR "Turks and Caicos Islands"[Title/Abstract] OR 
"United Arab Emirates"[Title/Abstract] OR "UAE"[Title/Abstract] OR 
"U.A.E."[Title/Abstract] OR "United Kingdom"[Title/Abstract] OR "UK"[Title/Abstract] OR 
"U.K."[Title/Abstract] OR "United States"[Title/Abstract] OR "USA"[Title/Abstract] OR 
"U.S.A."[Title/Abstract] OR "Uruguay"[Title/Abstract] OR "Virgin Islands 
(U.S.)"[Title/Abstract] OR "Virgin Islands"[Title/Abstract]) AND ("humans"[MeSH Terms]) 
AND (English[lang] OR French[lang] OR German[lang] OR Italian[lang] OR Portuguese[lang] OR 
Spanish[lang]) 
Scopus 
TITLE-ABS-KEY((earthquake* OR quake* OR seismic upheaval* OR seism* OR aftershock*) AND 
("Andorra" OR "Antigua and Barbuda" OR "Antigua" OR "Barbuda" OR "Aruba" OR "Australia" OR 
"Austria" OR "Bahamas" OR "Bahrain" OR "Barbados" OR "Belgium" OR "Bermuda" OR "Brunei" OR 
"Brunei Darussalam" OR "Canada" OR "Cayman Islands" OR "Cayman" OR "Channel Islands" OR 
"Chile" OR "Croatia" OR "Curaçao" OR "Cyprus" OR "Czech Republic" OR "Denmark" OR 
"Equatorial Guinea" OR "Estonia" OR "Faeroe Islands" OR "Finland" OR "France" OR 
"Polynesia" OR "French Polynesia" OR "Germany" OR "Greece" OR "Greenland" OR "Guam" OR 
"Hong Kong SAR, China" OR "Hong Kong" OR "Iceland" OR "Ireland" OR "Isle of Man" OR 
"Israel" OR "Italy" OR "Japan" OR "Korea, Rep." OR "Korea" OR "Kuwait" OR "Latvia" OR 
"Liechtenstein" OR "Lithuania" OR "Luxembourg" OR "Macao SAR, China" OR "Macao" OR "Malta" 
OR "Monaco" OR "Netherlands" OR "New Caledonia" OR "New Zealand" OR "Northern Mariana 
Islands" OR "Norway" OR "Oman" OR "Poland" OR "Portugal" OR "Puerto Rico" OR "Qatar" OR 
"Republic" OR "Russian Federation" OR "Russia" OR "San Marino" OR "Saudi Arabia" OR 
"Singapore" OR "Sint Maarten" OR "Slovak" OR "Slovenia" OR "Spain" OR "St. Kitts and 
Nevis" OR "St. Martin" OR "Sweden" OR "Switzerland" OR "Trinidad and Tobago" OR "Turks and 
Caicos Islands" OR "United Arab Emirates" OR "UAE" OR "U.A.E." OR "United Kingdom" OR "UK" 
OR "U.K." OR "United States" OR "USA" OR "U.S.A." OR "Uruguay" OR "Virgin Islands (U.S.)" 
OR "Virgin Islands")) AND ( LIMIT-TO(DOCTYPE,"ar" ) OR LIMIT-TO(DOCTYPE,"re" ) OR LIMIT-
TO(DOCTYPE,"ip" ) ) AND ( LIMIT-TO(LANGUAGE,"English" ) OR LIMIT-TO(LANGUAGE,"French" ) OR 
LIMIT-TO(LANGUAGE,"Spanish" ) OR LIMIT-TO(LANGUAGE,"German" ) OR LIMIT-
TO(LANGUAGE,"Italian" ) OR LIMIT-TO(LANGUAGE,"Portuguese" ) ) AND ( LIMIT-
TO(SUBJAREA,"MULT" ) OR LIMIT-TO(SUBJAREA,"MEDI" ) OR LIMIT-TO(SUBJAREA,"BIOC" ) OR LIMIT-
TO(SUBJAREA,"PSYC" ) OR LIMIT-TO(SUBJAREA,"NURS" ) OR LIMIT-TO(SUBJAREA,"NEUR" ) OR LIMIT-
TO(SUBJAREA,"HEAL" ) OR LIMIT-TO(SUBJAREA,"PHAR" ) OR LIMIT-TO(SUBJAREA,"IMMU" ) ) 
WHO 
allintitle: earthquake OR earthquakes OR quake OR quakes OR seism OR seismic OR aftershock 
OR aftershocks 
allintitle: seismic upheaval 
allintitle: seismic upheavals 
CDC 
earthquake OR earthquakes OR quake OR quakes OR seism OR seismic OR aftershock OR 
aftershocks OR (seismic AND upheaval) OR (seismic AND upheavals) 
NIH 
earthquake OR earthquakes OR quake OR quakes OR seism OR seismic OR aftershock OR 
aftershocks OR (seismic AND upheaval) OR (seismic AND upheavals) 
ECDC 
earthquake earthquakes quake quakes seism seismic aftershock aftershocks 
seismic upheaval 
seismic upheavals 
Epicentro 
"terremoto" OR "sisma" OR "sismico" OR "scossa" OR "scossa di assestamento" 
DORS 
"terremoto" OR "sisma" OR "sismico" OR "scossa" OR "scossa di assestamento" 
 
  
Supplementary Materials 2. Further details on data synthesis 
 
Unit conversions 
We harmonised units of continuous outcome by giving priority to the units used in the majority of the 
included studies. For example, we converted mmol/L to mg/dL multiplying cholesterol measurements by 
38.7 and triglycerides measurements by 88.6. We also converted µmol/L of uric acid to mg/dL multiplying 
estimates by 0.0168. 
 
Collapsing of within-study subgroups 
Fifteen studies reported estimates stratified not only by exposure status, but also by sex, age categories or 
other subgroups. We pooled within-study subgroup estimates to enable comparison of estimates between 
all exposed and unexposed participants for each outcome reported. For binary outcomes, we pooled 
estimates by summing subgroup-specific numerators and subgroup-specific denominators. For continuous 
outcomes, we used the formulae below as per Cochrane Collaboration recommendations 1. If there were 
more than two groups to combine, we applied the formulae sequentially. 
 Group 1 Group 2 Combined groups 
Sample size 𝑛1 𝑛2 𝑛1 + 𝑛2 
Mean ?̅?1 ?̅?2 𝑛1?̅?1 + 𝑛2?̅?2
𝑛1 + 𝑛2
 
Standard 
deviation 
𝑆𝐷1 𝑆𝐷2 
√
(𝑛1 − 1)𝑆𝐷1
2 + (𝑛2 − 1)𝑆𝐷2
2
𝑛1 + 𝑛2 − 1
 
 
 
Dealing with multiple comparison groups 
In studies reporting on more than two temporal comparison groups, such as multiple measurements carried 
out before and/or after the earthquake, we selected the latest pre-earthquake and the latest post-
earthquake data points. 
In studies reporting on more than two geographical comparison groups, we selected the group of individuals 
living closest to the earthquake epicentre and the group of residents furthest away from the epicentre. 
 
Reference 
1.  Higgins J, Green S. Cochrane Handbook for Systematic Reviews of Interventions [Internet]. 2011. 
Available from: www.cochrane-handbook.org 
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  5.00 [ -0.01,  10.01]
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 -0.40 [ -2.77,   1.97]
 -1.14 [ -2.87,   0.58]
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  4.00 [ -0.18,   8.18]
  2.26 [  0.03,   4.50]
-12.61 [-15.13, -10.09]
 -1.30 [ -3.19,   0.59]
 -0.40 [ -2.77,   1.97]
 -1.14 [ -2.87,   0.58]
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  3.80 [  2.64,   4.97]
Main analysis: All studies (temporal comparison)
Sensitivity analysis: Follow-up duration < 6 months (temporal comparison)
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Sensitivity analysis: Mean age < 50 years (temporal comparison)
Sensitivity analysis: Mean age >= 50 years (temporal comparison)
Sensitivity analysis: Occupational subgroups (temporal comparison)
Sensitivity analysis: Patient subgroups (temporal comparison)
Sensitivity analysis: Cohort (temporal comparison)
-0.91 [-5.06, 3.24]RE model (Heterog. p-value=2.7638e-28; I²=98.2%)
-0.90 [-5.01, 3.22]RE model (Heterog. p-value=4.2986e-23; I²=96.0%)
1.68 [-0.81, 4.17]RE model (Heterog. p-value=3.0156e-08; I²=92.0%)
-3.94 [-21.20, 13.31]RE model (Heterog. p-value=7.5374e-10; I²=97.4%)
0.45 [-1.37, 2.27]RE model (Heterog. p-value=7.5383e-08; I²=89.7%)
1.91 [-1.73, 5.54]RE model (Heterog. p-value=6.6472e-09; I²=97.0%)
-2.09 [-7.65, 3.47]RE model (Heterog. p-value=2.6452e-16; I²=96.3%)
1.91 [-1.73, 5.54]RE model (Heterog. p-value=6.6472e-09; I²=97.0%)
-2.09 [-7.65, 3.47]RE model (Heterog. p-value=2.6452e-16; I²=96.3%)
-0.91 [-5.06, 3.24]RE model (Heterog. p-value=2.7638e-28; I²=98.2%)
79 Cohort 606 505 88.2 (10.39) 84.4 (9.40) mmHg
2 Cohort 116 124 80.4 (2.92) 93.0 (14.00) mmHg
6 Cohort 222 222 75.4 (10.97) 76.0 (11.00) mmHg
12 Cohort 64 65 77.0 (15.00) 72.0 (14.00) mmHg
14 Cohort 4,035 4,035 74.4 (10.65) 74.3 (10.70) mmHg
3 Cohort 320 320 73.9 (11.29) 75.0 (11.00) mmHg
2 Cohort 205 205 77.1 (11.70) 77.5 (12.80) mmHg
2 Cohort 102 505 83.1 (8.80) 84.4 (9.40) mmHg
2 Cohort 116 124 80.4 (2.92) 93.0 (14.00) mmHg
3 Cohort 222 222 78.3 (12.95) 76.0 (11.00) mmHg
3 Cohort 65 65 76.0 (10.00) 72.0 (14.00) mmHg
5 Cohort 279 279 78.1 (10.30) 74.9 (10.30) mmHg
3 Cohort 320 320 73.9 (11.29) 75.0 (11.00) mmHg
2 Cohort 205 205 77.1 (11.70) 77.5 (12.80) mmHg
79 Cohort 606 505 88.2 (10.39) 84.4 (9.40) mmHg
6 Cohort 222 222 75.4 (10.97) 76.0 (11.00) mmHg
12 Cohort 64 65 77.0 (15.00) 72.0 (14.00) mmHg
14 Cohort 4,035 4,035 74.4 (10.65) 74.3 (10.70) mmHg
2 Cohort 116 124 80.4 (2.92) 93.0 (14.00) mmHg
12 Cohort 64 65 77.0 (15.00) 72.0 (14.00) mmHg
79 Cohort 606 505 88.2 (10.39) 84.4 (9.40) mmHg
6 Cohort 222 222 75.4 (10.97) 76.0 (11.00) mmHg
14 Cohort 4,035 4,035 74.4 (10.65) 74.3 (10.70) mmHg
3 Cohort 320 320 73.9 (11.29) 75.0 (11.00) mmHg
2 Cohort 205 205 77.1 (11.70) 77.5 (12.80) mmHg
79 Cohort 606 505 88.2 (10.39) 84.4 (9.40) mmHg
14 Cohort 4,035 4,035 74.4 (10.65) 74.3 (10.70) mmHg
2 Cohort 116 124 80.4 (2.92) 93.0 (14.00) mmHg
6 Cohort 222 222 75.4 (10.97) 76.0 (11.00) mmHg
12 Cohort 64 65 77.0 (15.00) 72.0 (14.00) mmHg
3 Cohort 320 320 73.9 (11.29) 75.0 (11.00) mmHg
2 Cohort 205 205 77.1 (11.70) 77.5 (12.80) mmHg
79 Cohort 606 505 88.2 (10.39) 84.4 (9.40) mmHg
14 Cohort 4,035 4,035 74.4 (10.65) 74.3 (10.70) mmHg
2 Cohort 116 124 80.4 (2.92) 93.0 (14.00) mmHg
6 Cohort 222 222 75.4 (10.97) 76.0 (11.00) mmHg
12 Cohort 64 65 77.0 (15.00) 72.0 (14.00) mmHg
3 Cohort 320 320 73.9 (11.29) 75.0 (11.00) mmHg
2 Cohort 205 205 77.1 (11.70) 77.5 (12.80) mmHg
79 Cohort 606 505 88.2 (10.39) 84.4 (9.40) mmHg
2 Cohort 116 124 80.4 (2.92) 93.0 (14.00) mmHg
6 Cohort 222 222 75.4 (10.97) 76.0 (11.00) mmHg
12 Cohort 64 65 77.0 (15.00) 72.0 (14.00) mmHg
14 Cohort 4,035 4,035 74.4 (10.65) 74.3 (10.70) mmHg
3 Cohort 320 320 73.9 (11.29) 75.0 (11.00) mmHg
2 Cohort 205 205 77.1 (11.70) 77.5 (12.80) mmHg
Follow-up
(months) Study design
Exposed
Participants
Unexposed
Participants
Exposed
Mean (SD)
Unexposed
Mean (SD) Unit
Clinically measured diastolic blood pressure
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-20.00 -10.00 0.00 10.00
Mean Difference (95% CI)
Great East Japan 2011 (Tani 2014)
Great East Japan 2011 (Fujihara 2012)
Niigata 2004 (Azuma 2010)
Niigata 2004 (Kamoi 2006b)
Niigata 2004 (Kamoi 2006a)
Kobe 1995 (Kario 2001)
Irpinia & Naples 1980 (Trevisan 1992)
Great East Japan 2011 (Tani 2014)
Great East Japan 2011 (Fujihara 2012)
Niigata 2004 (Kamoi 2006b)
Niigata 2004 (Kamoi 2006a)
Kobe 1995 (Kario 2001)
Niigata 2004 (Azuma 2010)
Irpinia & Naples 1980 (Trevisan 1992)
Great East Japan 2011 (Tani 2014)
Great East Japan 2011 (Fujihara 2012)
Niigata 2004 (Kamoi 2006b)
Niigata 2004 (Kamoi 2006a)
Kobe 1995 (Kario 2001)
Niigata 2004 (Azuma 2010)
Irpinia & Naples 1980 (Trevisan 1992)
Great East Japan 2011 (Tani 2014)
Great East Japan 2011 (Fujihara 2012)
Niigata 2004 (Azuma 2010)
Niigata 2004 (Kamoi 2006a)
Irpinia & Naples 1980 (Trevisan 1992)
Niigata 2004 (Kamoi 2006b)
Kobe 1995 (Kario 2001)
Niigata 2004 (Azuma 2010)
Niigata 2004 (Kamoi 2006b)
Niigata 2004 (Kamoi 2006a)
Irpinia & Naples 1980 (Trevisan 1992)
Great East Japan 2011 (Tani 2014)
Great East Japan 2011 (Fujihara 2012)
Niigata 2004 (Azuma 2010)
Niigata 2004 (Kamoi 2006b)
Niigata 2004 (Kamoi 2006a)
Kobe 1995 (Kario 2001)
Irpinia & Naples 1980 (Trevisan 1992)
Great East Japan 2011 (Tani 2014)
Great East Japan 2011 (Fujihara 2012)
Niigata 2004 (Azuma 2010)
Niigata 2004 (Kamoi 2006b)
Niigata 2004 (Kamoi 2006a)
Kobe 1995 (Kario 2001)
Irpinia & Naples 1980 (Trevisan 1992)
  1.00 [ -2.78,  4.78]
  0.57 [ -2.02,  3.17]
 -0.66 [ -1.23, -0.09]
  1.00 [ -5.51,  7.51]
 -0.87 [ -4.14,  2.41]
-12.63 [-16.28, -8.97]
 -1.20 [ -3.12,  0.73]
  1.00 [ -2.78,  4.78]
  0.57 [ -2.02,  3.17]
  1.00 [ -5.51,  7.51]
 -0.87 [ -4.14,  2.41]
-12.63 [-16.28, -8.97]
 -0.66 [ -1.23, -0.09]
 -1.20 [ -3.12,  0.73]
  1.00 [ -2.78,  4.78]
  0.57 [ -2.02,  3.17]
  1.00 [ -5.51,  7.51]
 -0.87 [ -4.14,  2.41]
-12.63 [-16.28, -8.97]
 -0.66 [ -1.23, -0.09]
 -1.20 [ -3.12,  0.73]
  1.00 [ -2.78,  4.78]
  0.57 [ -2.02,  3.17]
 -0.66 [ -1.23, -0.09]
 -0.87 [ -4.14,  2.41]
 -1.20 [ -3.12,  0.73]
  1.00 [ -5.51,  7.51]
-12.63 [-16.28, -8.97]
 -0.66 [ -1.23, -0.09]
  1.00 [ -5.51,  7.51]
 -0.87 [ -4.14,  2.41]
 -1.20 [ -3.12,  0.73]
  1.00 [ -2.78,  4.78]
  0.57 [ -2.02,  3.17]
  4.40 [  2.12,  6.68]
  4.00 [ -1.51,  9.51]
  2.52 [ -0.79,  5.83]
-12.63 [-16.28, -8.97]
 -0.40 [ -3.15,  2.35]
  1.00 [ -2.78,  4.78]
  0.57 [ -2.02,  3.17]
 -0.66 [ -1.23, -0.09]
  1.00 [ -5.51,  7.51]
 -0.87 [ -4.14,  2.41]
-12.63 [-16.28, -8.97]
 -1.20 [ -3.12,  0.73]
Main analysis: All studies (temporal comparison)
Sensitivity analysis: Follow-up duration < 6 months (temporal comparison)
Sensitivity analysis: Follow-up duration >= 6 months (temporal comparison)
Sensitivity analysis: % males < 50% (temporal comparison)
Sensitivity analysis: % males >= 50% (temporal comparison)
Sensitivity analysis: Mean age < 50 years (temporal comparison)
Sensitivity analysis: Mean age >= 50 years (temporal comparison)
Sensitivity analysis: Occupational subgroups (temporal comparison)
Sensitivity analysis: Patient subgroups (temporal comparison)
Sensitivity analysis: Cohort (temporal comparison)
-1.86 [-5.35, 1.64]RE model (Heterog. p-value=1.2482e-07; I²=93.7%)
-0.09 [-4.35, 4.17]RE model (Heterog. p-value=6.0876e-12; I²=92.1%)
-0.70 [-1.24, -0.16]RE model (Heterog. p-value=0.9085; I²=0.0%)
-6.09 [-19.43, 7.25]RE model (Heterog. p-value=0.0003; I²=92.2%)
-0.62 [-1.15, -0.10]RE model (Heterog. p-value=0.7522; I²=0.0%)
-0.70 [-1.25, -0.16]RE model (Heterog. p-value=0.6003; I²=0.0%)
-2.27 [-7.50, 2.97]RE model (Heterog. p-value=4.3522e-08; I²=90.3%)
-0.70 [-1.25, -0.16]RE model (Heterog. p-value=0.6003; I²=0.0%)
-2.27 [-7.50, 2.97]RE model (Heterog. p-value=4.3522e-08; I²=90.3%)
-1.86 [-5.35, 1.64]RE model (Heterog. p-value=1.2482e-07; I²=93.7%)
79 Cohort 606 505 129.4 (17.85) 130.6 (14.90) mmHg
2 Cohort 116 124 149.4 (5.37) 162.0 (20.00) mmHg
6 Cohort 222 222 132.1 (17.16) 133.0 (18.00) mmHg
12 Cohort 64 65 127.0 (22.00) 126.0 (15.00) mmHg
14 Cohort 4,035 4,035 120.1 (14.75) 120.8 (11.32) mmHg
3 Cohort 320 320 131.6 (17.43) 131.0 (16.00) mmHg
2 Cohort 205 205 149.6 (19.00) 148.6 (20.00) mmHg
2 Cohort 102 505 130.2 (12.50) 130.6 (14.90) mmHg
2 Cohort 116 124 149.4 (5.37) 162.0 (20.00) mmHg
3 Cohort 222 222 135.5 (17.59) 133.0 (18.00) mmHg
3 Cohort 65 65 130.0 (17.00) 126.0 (15.00) mmHg
5 Cohort 279 279 125.2 (14.20) 120.8 (13.30) mmHg
3 Cohort 320 320 131.6 (17.43) 131.0 (16.00) mmHg
2 Cohort 205 205 149.6 (19.00) 148.6 (20.00) mmHg
79 Cohort 606 505 129.4 (17.85) 130.6 (14.90) mmHg
6 Cohort 222 222 132.1 (17.16) 133.0 (18.00) mmHg
12 Cohort 64 65 127.0 (22.00) 126.0 (15.00) mmHg
14 Cohort 4,035 4,035 120.1 (14.75) 120.8 (11.32) mmHg
2 Cohort 116 124 149.4 (5.37) 162.0 (20.00) mmHg
12 Cohort 64 65 127.0 (22.00) 126.0 (15.00) mmHg
79 Cohort 606 505 129.4 (17.85) 130.6 (14.90) mmHg
6 Cohort 222 222 132.1 (17.16) 133.0 (18.00) mmHg
14 Cohort 4,035 4,035 120.1 (14.75) 120.8 (11.32) mmHg
3 Cohort 320 320 131.6 (17.43) 131.0 (16.00) mmHg
2 Cohort 205 205 149.6 (19.00) 148.6 (20.00) mmHg
79 Cohort 606 505 129.4 (17.85) 130.6 (14.90) mmHg
14 Cohort 4,035 4,035 120.1 (14.75) 120.8 (11.32) mmHg
2 Cohort 116 124 149.4 (5.37) 162.0 (20.00) mmHg
6 Cohort 222 222 132.1 (17.16) 133.0 (18.00) mmHg
12 Cohort 64 65 127.0 (22.00) 126.0 (15.00) mmHg
3 Cohort 320 320 131.6 (17.43) 131.0 (16.00) mmHg
2 Cohort 205 205 149.6 (19.00) 148.6 (20.00) mmHg
79 Cohort 606 505 129.4 (17.85) 130.6 (14.90) mmHg
14 Cohort 4,035 4,035 120.1 (14.75) 120.8 (11.32) mmHg
2 Cohort 116 124 149.4 (5.37) 162.0 (20.00) mmHg
6 Cohort 222 222 132.1 (17.16) 133.0 (18.00) mmHg
12 Cohort 64 65 127.0 (22.00) 126.0 (15.00) mmHg
3 Cohort 320 320 131.6 (17.43) 131.0 (16.00) mmHg
2 Cohort 205 205 149.6 (19.00) 148.6 (20.00) mmHg
79 Cohort 606 505 129.4 (17.85) 130.6 (14.90) mmHg
2 Cohort 116 124 149.4 (5.37) 162.0 (20.00) mmHg
6 Cohort 222 222 132.1 (17.16) 133.0 (18.00) mmHg
12 Cohort 64 65 127.0 (22.00) 126.0 (15.00) mmHg
14 Cohort 4,035 4,035 120.1 (14.75) 120.8 (11.32) mmHg
3 Cohort 320 320 131.6 (17.43) 131.0 (16.00) mmHg
2 Cohort 205 205 149.6 (19.00) 148.6 (20.00) mmHg
Follow-up
(months) Study design
Exposed
Participants
Unexposed
Participants
Exposed
Mean (SD)
Unexposed
Mean (SD) Unit
Clinically measured systolic blood pressure
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-2.00 -1.00 0.00 1.00 2.00
Mean Difference (95% CI)
Great East Japan 2011 (Fujihara 2012)
Niigata 2004 (Azuma 2010)
Niigata 2004 (Kamoi 2006b)
Niigata 2004 (Kamoi 2006a)
Irpinia & Naples 1980 (Trevisan 1992)
Great East Japan 2011 (Fujihara 2012)
Niigata 2004 (Kamoi 2006b)
Niigata 2004 (Kamoi 2006a)
Niigata 2004 (Azuma 2010)
Irpinia & Naples 1980 (Trevisan 1992)
Great East Japan 2011 (Fujihara 2012)
Niigata 2004 (Kamoi 2006b)
Niigata 2004 (Kamoi 2006a)
Niigata 2004 (Azuma 2010)
Irpinia & Naples 1980 (Trevisan 1992)
Great East Japan 2011 (Fujihara 2012)
Niigata 2004 (Azuma 2010)
Niigata 2004 (Kamoi 2006a)
Irpinia & Naples 1980 (Trevisan 1992)
Niigata 2004 (Kamoi 2006b)
Niigata 2004 (Azuma 2010)
Niigata 2004 (Kamoi 2006b)
Niigata 2004 (Kamoi 2006a)
Irpinia & Naples 1980 (Trevisan 1992)
Great East Japan 2011 (Fujihara 2012)
Niigata 2004 (Azuma 2010)
Niigata 2004 (Kamoi 2006b)
Niigata 2004 (Kamoi 2006a)
Irpinia & Naples 1980 (Trevisan 1992)
Great East Japan 2011 (Fujihara 2012)
Niigata 2004 (Azuma 2010)
Niigata 2004 (Kamoi 2006b)
Niigata 2004 (Kamoi 2006a)
Irpinia & Naples 1980 (Trevisan 1992)
-0.07 [-0.70, 0.56]
-0.12 [-0.25, 0.01]
 0.00 [-1.22, 1.22]
 0.00 [-0.56, 0.56]
 0.58 [-0.17, 1.33]
-0.07 [-0.70, 0.56]
 0.00 [-1.22, 1.22]
 0.00 [-0.56, 0.56]
-0.12 [-0.25, 0.01]
 0.58 [-0.17, 1.33]
-0.07 [-0.70, 0.56]
 0.00 [-1.22, 1.22]
 0.00 [-0.56, 0.56]
-0.12 [-0.25, 0.01]
 0.58 [-0.17, 1.33]
-0.07 [-0.70, 0.56]
-0.12 [-0.25, 0.01]
 0.00 [-0.56, 0.56]
 0.58 [-0.17, 1.33]
 0.00 [-1.22, 1.22]
-0.12 [-0.25, 0.01]
 0.00 [-1.22, 1.22]
 0.00 [-0.56, 0.56]
 0.58 [-0.17, 1.33]
-0.07 [-0.70, 0.56]
 0.40 [-0.08, 0.88]
 0.00 [-1.03, 1.03]
 0.00 [-0.60, 0.60]
 0.10 [-0.52, 0.72]
-0.07 [-0.70, 0.56]
-0.12 [-0.25, 0.01]
 0.00 [-1.22, 1.22]
 0.00 [-0.56, 0.56]
 0.58 [-0.17, 1.33]
Main analysis: All studies (temporal comparison)
Sensitivity analysis: Follow-up duration < 6 months (temporal comparison)
Sensitivity analysis: Follow-up duration >= 6 months (temporal comparison)
Sensitivity analysis: % males < 50% (temporal comparison)
Sensitivity analysis: % males >= 50% (temporal comparison)
Sensitivity analysis: Mean age < 50 years (temporal comparison)
Sensitivity analysis: Mean age >= 50 years (temporal comparison)
Sensitivity analysis: Occupational subgroups (temporal comparison)
Sensitivity analysis: Patient subgroups (temporal comparison)
Sensitivity analysis: Cohort (temporal comparison)
-0.08 [-0.23, 0.06]RE model (Heterog. p-value=0.4870; I²=3.2%)
0.14 [-0.14, 0.41]RE model (Heterog. p-value=0.7637; I²=0.0%)
-0.02 [-0.28, 0.24]RE model (Heterog. p-value=0.3293; I²=22.2%)
-0.08 [-0.24, 0.09]RE model (Heterog. p-value=0.3316; I²=6.9%)
0.13 [-0.53, 0.79]RE model (Heterog. p-value=0.0696; I²=69.6%)
-0.03 [-0.42, 0.37]RE model (Heterog. p-value=0.9855; I²=0.0%)
0.13 [-0.53, 0.79]RE model (Heterog. p-value=0.0696; I²=69.6%)
-0.03 [-0.42, 0.37]RE model (Heterog. p-value=0.9855; I²=0.0%)
-0.08 [-0.23, 0.06]RE model (Heterog. p-value=0.4870; I²=3.2%)
79 Cohort 102 505 26.5 (3.60) 25.9 (3.10) Kg/m²
6 Cohort 222 222 24.0 (2.99) 24.0 (3.00) Kg/m²
12 Cohort 64 65 22.0 (4.00) 22.0 (3.00) Kg/m²
14 Cohort 4,035 4,035 22.5 (2.95) 22.7 (3.00) Kg/m²
3 Cohort 320 320 24.2 (4.04) 24.3 (4.10) Kg/m²
2 Cohort 102 505 26.0 (2.90) 25.9 (3.10) Kg/m²
3 Cohort 222 222 24.0 (3.40) 24.0 (3.00) Kg/m²
3 Cohort 65 65 22.0 (3.00) 22.0 (3.00) Kg/m²
5 Cohort 279 279 23.4 (2.90) 23.0 (2.90) Kg/m²
3 Cohort 320 320 24.2 (4.04) 24.3 (4.10) Kg/m²
79 Cohort 102 505 26.5 (3.60) 25.9 (3.10) Kg/m²
6 Cohort 222 222 24.0 (2.99) 24.0 (3.00) Kg/m²
12 Cohort 64 65 22.0 (4.00) 22.0 (3.00) Kg/m²
14 Cohort 4,035 4,035 22.5 (2.95) 22.7 (3.00) Kg/m²
12 Cohort 64 65 22.0 (4.00) 22.0 (3.00) Kg/m²
79 Cohort 102 505 26.5 (3.60) 25.9 (3.10) Kg/m²
6 Cohort 222 222 24.0 (2.99) 24.0 (3.00) Kg/m²
14 Cohort 4,035 4,035 22.5 (2.95) 22.7 (3.00) Kg/m²
3 Cohort 320 320 24.2 (4.04) 24.3 (4.10) Kg/m²
79 Cohort 102 505 26.5 (3.60) 25.9 (3.10) Kg/m²
14 Cohort 4,035 4,035 22.5 (2.95) 22.7 (3.00) Kg/m²
6 Cohort 222 222 24.0 (2.99) 24.0 (3.00) Kg/m²
12 Cohort 64 65 22.0 (4.00) 22.0 (3.00) Kg/m²
3 Cohort 320 320 24.2 (4.04) 24.3 (4.10) Kg/m²
79 Cohort 102 505 26.5 (3.60) 25.9 (3.10) Kg/m²
14 Cohort 4,035 4,035 22.5 (2.95) 22.7 (3.00) Kg/m²
6 Cohort 222 222 24.0 (2.99) 24.0 (3.00) Kg/m²
12 Cohort 64 65 22.0 (4.00) 22.0 (3.00) Kg/m²
3 Cohort 320 320 24.2 (4.04) 24.3 (4.10) Kg/m²
79 Cohort 102 505 26.5 (3.60) 25.9 (3.10) Kg/m²
6 Cohort 222 222 24.0 (2.99) 24.0 (3.00) Kg/m²
12 Cohort 64 65 22.0 (4.00) 22.0 (3.00) Kg/m²
14 Cohort 4,035 4,035 22.5 (2.95) 22.7 (3.00) Kg/m²
3 Cohort 320 320 24.2 (4.04) 24.3 (4.10) Kg/m²
Follow-up
(months) Study design
Exposed
Participants
Unexposed
Participants
Exposed
Mean (SD)
Unexposed
Mean (SD) Unit
Body mass index
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-20.00 0.00 20.00
Mean Difference (95% CI)
Great East Japan 2011 (Fujihara 2012)
Niigata 2004 (Azuma 2010)
Niigata 2004 (Kamoi 2006b)
Niigata 2004 (Kamoi 2006a)
Irpinia & Naples 1980 (Trevisan 1992)
Great East Japan 2011 (Fujihara 2012)
Niigata 2004 (Kamoi 2006b)
Niigata 2004 (Kamoi 2006a)
Niigata 2004 (Azuma 2010)
Irpinia & Naples 1980 (Trevisan 1992)
Great East Japan 2011 (Fujihara 2012)
Niigata 2004 (Kamoi 2006b)
Niigata 2004 (Kamoi 2006a)
Niigata 2004 (Azuma 2010)
Irpinia & Naples 1980 (Trevisan 1992)
Great East Japan 2011 (Fujihara 2012)
Niigata 2004 (Azuma 2010)
Niigata 2004 (Kamoi 2006a)
Irpinia & Naples 1980 (Trevisan 1992)
Niigata 2004 (Kamoi 2006b)
Niigata 2004 (Azuma 2010)
Niigata 2004 (Kamoi 2006b)
Niigata 2004 (Kamoi 2006a)
Irpinia & Naples 1980 (Trevisan 1992)
Great East Japan 2011 (Fujihara 2012)
Niigata 2004 (Azuma 2010)
Niigata 2004 (Kamoi 2006b)
Niigata 2004 (Kamoi 2006a)
Irpinia & Naples 1980 (Trevisan 1992)
Great East Japan 2011 (Fujihara 2012)
Niigata 2004 (Azuma 2010)
Niigata 2004 (Kamoi 2006b)
Niigata 2004 (Kamoi 2006a)
Irpinia & Naples 1980 (Trevisan 1992)
 1.93 [ -3.43,  7.29]
-0.21 [ -1.65,  1.23]
 0.00 [-10.70, 10.70]
 0.15 [ -4.88,  5.19]
 7.47 [  0.60, 14.34]
 1.93 [ -3.43,  7.29]
 0.00 [-10.70, 10.70]
 0.15 [ -4.88,  5.19]
-0.21 [ -1.65,  1.23]
 7.47 [  0.60, 14.34]
 1.93 [ -3.43,  7.29]
 0.00 [-10.70, 10.70]
 0.15 [ -4.88,  5.19]
-0.21 [ -1.65,  1.23]
 7.47 [  0.60, 14.34]
 1.93 [ -3.43,  7.29]
-0.21 [ -1.65,  1.23]
 0.15 [ -4.88,  5.19]
 7.47 [  0.60, 14.34]
 0.00 [-10.70, 10.70]
-0.21 [ -1.65,  1.23]
 0.00 [-10.70, 10.70]
 0.15 [ -4.88,  5.19]
 7.47 [  0.60, 14.34]
 1.93 [ -3.43,  7.29]
 7.73 [  2.82, 12.64]
10.00 [ -1.37, 21.37]
 5.48 [ -0.69, 11.64]
14.70 [  7.72, 21.68]
 1.93 [ -3.43,  7.29]
-0.21 [ -1.65,  1.23]
 0.00 [-10.70, 10.70]
 0.15 [ -4.88,  5.19]
 7.47 [  0.60, 14.34]
Main analysis: All studies (temporal comparison)
Sensitivity analysis: Follow-up duration < 6 months (temporal comparison)
Sensitivity analysis: Follow-up duration >= 6 months (temporal comparison)
Sensitivity analysis: % males < 50% (temporal comparison)
Sensitivity analysis: % males >= 50% (temporal comparison)
Sensitivity analysis: Mean age < 50 years (temporal comparison)
Sensitivity analysis: Mean age >= 50 years (temporal comparison)
Sensitivity analysis: Occupational subgroups (temporal comparison)
Sensitivity analysis: Patient subgroups (temporal comparison)
Sensitivity analysis: Cohort (temporal comparison)
0.83 [-1.35, 3.02]RE model (Heterog. p-value=0.2860; I²=21.9%)
7.44 [3.08, 11.79]RE model (Heterog. p-value=0.0691; I²=55.9%)
0.98 [-1.95, 3.90]RE model (Heterog. p-value=0.2037; I²=35.3%)
1.05 [-1.44, 3.55]RE model (Heterog. p-value=0.1710; I²=34.5%)
2.87 [-4.51, 10.24]RE model (Heterog. p-value=0.0320; I²=78.2%)
0.88 [-2.59, 4.36]RE model (Heterog. p-value=0.8805; I²=0.0%)
2.87 [-4.51, 10.24]RE model (Heterog. p-value=0.0320; I²=78.2%)
0.88 [-2.59, 4.36]RE model (Heterog. p-value=0.8805; I²=0.0%)
0.83 [-1.35, 3.02]RE model (Heterog. p-value=0.2860; I²=21.9%)
79 Cohort 102 505 202.3 (32.19) 194.8 (32.80) mg/dL
6 Cohort 222 222 197.2 (19.40) 197.0 (33.00) mg/dL
12 Cohort 64 65 195.0 (31.00) 195.0 (31.00) mg/dL
14 Cohort 4,035 4,035 198.5 (32.95) 198.7 (33.16) mg/dL
3 Cohort 320 320 194.1 (33.98) 192.2 (35.19) mg/dL
2 Cohort 102 505 209.5 (32.80) 194.8 (32.80) mg/dL
3 Cohort 222 222 202.5 (33.30) 197.0 (33.00) mg/dL
3 Cohort 65 65 205.0 (35.00) 195.0 (31.00) mg/dL
5 Cohort 279 279 200.3 (30.16) 192.6 (29.00) mg/dL
3 Cohort 320 320 194.1 (33.98) 192.2 (35.19) mg/dL
79 Cohort 102 505 202.3 (32.19) 194.8 (32.80) mg/dL
6 Cohort 222 222 197.2 (19.40) 197.0 (33.00) mg/dL
12 Cohort 64 65 195.0 (31.00) 195.0 (31.00) mg/dL
14 Cohort 4,035 4,035 198.5 (32.95) 198.7 (33.16) mg/dL
12 Cohort 64 65 195.0 (31.00) 195.0 (31.00) mg/dL
79 Cohort 102 505 202.3 (32.19) 194.8 (32.80) mg/dL
6 Cohort 222 222 197.2 (19.40) 197.0 (33.00) mg/dL
14 Cohort 4,035 4,035 198.5 (32.95) 198.7 (33.16) mg/dL
3 Cohort 320 320 194.1 (33.98) 192.2 (35.19) mg/dL
79 Cohort 102 505 202.3 (32.19) 194.8 (32.80) mg/dL
14 Cohort 4,035 4,035 198.5 (32.95) 198.7 (33.16) mg/dL
6 Cohort 222 222 197.2 (19.40) 197.0 (33.00) mg/dL
12 Cohort 64 65 195.0 (31.00) 195.0 (31.00) mg/dL
3 Cohort 320 320 194.1 (33.98) 192.2 (35.19) mg/dL
79 Cohort 102 505 202.3 (32.19) 194.8 (32.80) mg/dL
14 Cohort 4,035 4,035 198.5 (32.95) 198.7 (33.16) mg/dL
6 Cohort 222 222 197.2 (19.40) 197.0 (33.00) mg/dL
12 Cohort 64 65 195.0 (31.00) 195.0 (31.00) mg/dL
3 Cohort 320 320 194.1 (33.98) 192.2 (35.19) mg/dL
79 Cohort 102 505 202.3 (32.19) 194.8 (32.80) mg/dL
6 Cohort 222 222 197.2 (19.40) 197.0 (33.00) mg/dL
12 Cohort 64 65 195.0 (31.00) 195.0 (31.00) mg/dL
14 Cohort 4,035 4,035 198.5 (32.95) 198.7 (33.16) mg/dL
3 Cohort 320 320 194.1 (33.98) 192.2 (35.19) mg/dL
Follow-up
(months) Study design
Exposed
Participants
Unexposed
Participants
Exposed
Mean (SD)
Unexposed
Mean (SD) Unit
Total cholesterol
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-0.50 0.00 0.50 1.00
Mean Difference (95% CI)
Great East Japan 2011 (Fujihara 2012)
Niigata 2004 (Kamoi 2006b)
Niigata 2004 (Kamoi 2006a)
Kobe 1995 (Inui 1998)
Great East Japan 2011 (Fujihara 2012)
Niigata 2004 (Kamoi 2006b)
Niigata 2004 (Kamoi 2006a)
Kobe 1995 (Inui 1998)
Great East Japan 2011 (Fujihara 2012)
Niigata 2004 (Kamoi 2006b)
Niigata 2004 (Kamoi 2006a)
Kobe 1995 (Inui 1998)
Great East Japan 2011 (Fujihara 2012)
Niigata 2004 (Kamoi 2006a)
Niigata 2004 (Kamoi 2006b)
Kobe 1995 (Inui 1998)
Niigata 2004 (Kamoi 2006b)
Niigata 2004 (Kamoi 2006a)
Great East Japan 2011 (Fujihara 2012)
Niigata 2004 (Kamoi 2006b)
Niigata 2004 (Kamoi 2006a)
Kobe 1995 (Inui 1998)
Great East Japan 2011 (Fujihara 2012)
Niigata 2004 (Kamoi 2006b)
Niigata 2004 (Kamoi 2006a)
Kobe 1995 (Inui 1998)
0.00 [-0.21, 0.21]
0.30 [-0.05, 0.65]
0.12 [-0.08, 0.31]
0.20 [ 0.17, 0.23]
0.00 [-0.21, 0.21]
0.30 [-0.05, 0.65]
0.12 [-0.08, 0.31]
0.20 [ 0.17, 0.23]
0.00 [-0.21, 0.21]
0.30 [-0.05, 0.65]
0.12 [-0.08, 0.31]
0.20 [ 0.17, 0.23]
0.00 [-0.21, 0.21]
0.12 [-0.08, 0.31]
0.30 [-0.05, 0.65]
0.20 [ 0.17, 0.23]
0.30 [-0.05, 0.65]
0.12 [-0.08, 0.31]
0.00 [-0.21, 0.21]
0.30 [-0.03, 0.63]
0.14 [-0.06, 0.34]
0.20 [ 0.17, 0.23]
0.00 [-0.21, 0.21]
0.30 [-0.05, 0.65]
0.12 [-0.08, 0.31]
0.20 [ 0.17, 0.23]
Main analysis: All studies (temporal comparison)
Sensitivity analysis: Follow-up duration < 6 months (temporal comparison)
Sensitivity analysis: Follow-up duration >= 6 months (temporal comparison)
Sensitivity analysis: % males < 50% (temporal comparison)
Sensitivity analysis: % males >= 50% (temporal comparison)
Sensitivity analysis: Mean age >= 50 years (temporal comparison)
Sensitivity analysis: Patient subgroups (temporal comparison)
Sensitivity analysis: Cohort (temporal comparison)
0.16 [0.07, 0.25]RE model (Heterog. p-value=0.2193; I²=33.3%)
0.17 [0.08, 0.26]RE model (Heterog. p-value=0.2475; I²=27.2%)
0.16 [-0.01, 0.33]RE model (Heterog. p-value=0.3605; I²=0.0%)
0.20 [0.17, 0.24]RE model (Heterog. p-value=0.5742; I²=0.0%)
0.06 [-0.08, 0.20]RE model (Heterog. p-value=0.4270; I²=0.0%)
0.16 [0.07, 0.25]RE model (Heterog. p-value=0.2193; I²=33.3%)
0.16 [0.07, 0.25]RE model (Heterog. p-value=0.2193; I²=33.3%)
0.16 [0.07, 0.25]RE model (Heterog. p-value=0.2193; I²=33.3%)
2 Cohort 110 110 7.6 (0.11) 7.4 (0.15) %
6 Cohort 222 222 6.9 (1.06) 6.8 (1.00) %
12 Cohort 64 65 7.0 (1.10) 6.7 (0.90) %
3 Cohort 320 320 7.7 (1.40) 7.7 (1.30) %
2 Cohort 110 110 7.6 (0.11) 7.4 (0.15) %
3 Cohort 222 222 6.9 (1.14) 6.8 (1.00) %
3 Cohort 65 65 7.0 (1.00) 6.7 (0.90) %
3 Cohort 320 320 7.7 (1.40) 7.7 (1.30) %
6 Cohort 222 222 6.9 (1.06) 6.8 (1.00) %
12 Cohort 64 65 7.0 (1.10) 6.7 (0.90) %
2 Cohort 110 110 7.6 (0.11) 7.4 (0.15) %
12 Cohort 64 65 7.0 (1.10) 6.7 (0.90) %
6 Cohort 222 222 6.9 (1.06) 6.8 (1.00) %
3 Cohort 320 320 7.7 (1.40) 7.7 (1.30) %
2 Cohort 110 110 7.6 (0.11) 7.4 (0.15) %
6 Cohort 222 222 6.9 (1.06) 6.8 (1.00) %
12 Cohort 64 65 7.0 (1.10) 6.7 (0.90) %
3 Cohort 320 320 7.7 (1.40) 7.7 (1.30) %
2 Cohort 110 110 7.6 (0.11) 7.4 (0.15) %
6 Cohort 222 222 6.9 (1.06) 6.8 (1.00) %
12 Cohort 64 65 7.0 (1.10) 6.7 (0.90) %
3 Cohort 320 320 7.7 (1.40) 7.7 (1.30) %
2 Cohort 110 110 7.6 (0.11) 7.4 (0.15) %
6 Cohort 222 222 6.9 (1.06) 6.8 (1.00) %
12 Cohort 64 65 7.0 (1.10) 6.7 (0.90) %
3 Cohort 320 320 7.7 (1.40) 7.7 (1.30) %
Follow-up
(months) Study design
Exposed
Participants
Unexposed
Participants
Exposed
Mean (SD)
Unexposed
Mean (SD) Unit
Glycated haemoglobin
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-10.00 0.00 5.00 10.00
Mean Difference (95% CI)
Great East Japan 2011 (Fujihara 2012)
Niigata 2004 (Azuma 2010)
Niigata 2004 (Kamoi 2006b)
Niigata 2004 (Kamoi 2006a)
Great East Japan 2011 (Fujihara 2012)
Niigata 2004 (Kamoi 2006b)
Niigata 2004 (Kamoi 2006a)
Niigata 2004 (Azuma 2010)
Great East Japan 2011 (Fujihara 2012)
Niigata 2004 (Kamoi 2006b)
Niigata 2004 (Kamoi 2006a)
Niigata 2004 (Azuma 2010)
Great East Japan 2011 (Fujihara 2012)
Niigata 2004 (Azuma 2010)
Niigata 2004 (Kamoi 2006a)
Niigata 2004 (Kamoi 2006b)
Niigata 2004 (Azuma 2010)
Niigata 2004 (Kamoi 2006b)
Niigata 2004 (Kamoi 2006a)
Great East Japan 2011 (Fujihara 2012)
Niigata 2004 (Azuma 2010)
Niigata 2004 (Kamoi 2006b)
Niigata 2004 (Kamoi 2006a)
Great East Japan 2011 (Fujihara 2012)
Niigata 2004 (Azuma 2010)
Niigata 2004 (Kamoi 2006b)
Niigata 2004 (Kamoi 2006a)
 0.00 [-2.45, 2.45]
-0.42 [-1.07, 0.23]
 0.00 [-6.04, 6.04]
 2.29 [-0.97, 5.54]
 0.00 [-2.45, 2.45]
 0.00 [-6.04, 6.04]
 2.29 [-0.97, 5.54]
-0.42 [-1.07, 0.23]
 0.00 [-2.45, 2.45]
 0.00 [-6.04, 6.04]
 2.29 [-0.97, 5.54]
-0.42 [-1.07, 0.23]
 0.00 [-2.45, 2.45]
-0.42 [-1.07, 0.23]
 2.29 [-0.97, 5.54]
 0.00 [-6.04, 6.04]
-0.42 [-1.07, 0.23]
 0.00 [-6.04, 6.04]
 2.29 [-0.97, 5.54]
 0.00 [-2.45, 2.45]
 0.77 [-1.54, 3.08]
 0.00 [-6.57, 6.57]
-1.37 [-4.65, 1.91]
 0.00 [-2.45, 2.45]
-0.42 [-1.07, 0.23]
 0.00 [-6.04, 6.04]
 2.29 [-0.97, 5.54]
Main analysis: All studies (temporal comparison)
Sensitivity analysis: Follow-up duration < 6 months (temporal comparison)
Sensitivity analysis: Follow-up duration >= 6 months (temporal comparison)
Sensitivity analysis: % males < 50% (temporal comparison)
Sensitivity analysis: % males >= 50% (temporal comparison)
Sensitivity analysis: Mean age < 50 years (temporal comparison)
Sensitivity analysis: Mean age >= 50 years (temporal comparison)
Sensitivity analysis: Occupational subgroups (temporal comparison)
Sensitivity analysis: Patient subgroups (temporal comparison)
Sensitivity analysis: Cohort (temporal comparison)
-0.21 [-1.01, 0.58]RE model (Heterog. p-value=0.4530; I²=5.8%)
0.04 [-1.42, 1.50]RE model (Heterog. p-value=0.7777; I²=0.0%)
0.23 [-1.63, 2.09]RE model (Heterog. p-value=0.2770; I²=35.0%)
-0.15 [-1.10, 0.80]RE model (Heterog. p-value=0.2703; I²=14.9%)
0.75 [-1.11, 2.62]RE model (Heterog. p-value=0.5283; I²=0.0%)
0.75 [-1.11, 2.62]RE model (Heterog. p-value=0.5283; I²=0.0%)
-0.21 [-1.01, 0.58]RE model (Heterog. p-value=0.4530; I²=5.8%)
6 Cohort 222 222 58.3 (16.96) 56.0 (18.00) mg/dL
12 Cohort 64 65 68.0 (18.00) 68.0 (17.00) mg/dL
14 Cohort 4,035 4,035 59.8 (13.95) 60.2 (15.75) mg/dL
3 Cohort 320 320 54.1 (15.83) 54.1 (15.85) mg/dL
3 Cohort 222 222 54.6 (17.25) 56.0 (18.00) mg/dL
3 Cohort 65 65 68.0 (21.00) 68.0 (17.00) mg/dL
5 Cohort 279 279 57.6 (13.92) 56.8 (13.92) mg/dL
3 Cohort 320 320 54.1 (15.83) 54.1 (15.85) mg/dL
6 Cohort 222 222 58.3 (16.96) 56.0 (18.00) mg/dL
12 Cohort 64 65 68.0 (18.00) 68.0 (17.00) mg/dL
14 Cohort 4,035 4,035 59.8 (13.95) 60.2 (15.75) mg/dL
12 Cohort 64 65 68.0 (18.00) 68.0 (17.00) mg/dL
6 Cohort 222 222 58.3 (16.96) 56.0 (18.00) mg/dL
14 Cohort 4,035 4,035 59.8 (13.95) 60.2 (15.75) mg/dL
3 Cohort 320 320 54.1 (15.83) 54.1 (15.85) mg/dL
14 Cohort 4,035 4,035 59.8 (13.95) 60.2 (15.75) mg/dL
6 Cohort 222 222 58.3 (16.96) 56.0 (18.00) mg/dL
12 Cohort 64 65 68.0 (18.00) 68.0 (17.00) mg/dL
3 Cohort 320 320 54.1 (15.83) 54.1 (15.85) mg/dL
14 Cohort 4,035 4,035 59.8 (13.95) 60.2 (15.75) mg/dL
6 Cohort 222 222 58.3 (16.96) 56.0 (18.00) mg/dL
12 Cohort 64 65 68.0 (18.00) 68.0 (17.00) mg/dL
3 Cohort 320 320 54.1 (15.83) 54.1 (15.85) mg/dL
6 Cohort 222 222 58.3 (16.96) 56.0 (18.00) mg/dL
12 Cohort 64 65 68.0 (18.00) 68.0 (17.00) mg/dL
14 Cohort 4,035 4,035 59.8 (13.95) 60.2 (15.75) mg/dL
3 Cohort 320 320 54.1 (15.83) 54.1 (15.85) mg/dL
Follow-up
(months) Study design
Exposed
Participants
Unexposed
Participants
Exposed
Mean (SD)
Unexposed
Mean (SD) Unit
HDL cholesterol
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1.00 1.20 1.40 1.60
Incidence Rate Ratio (95% CI)
Great East Japan 2011 (Takegami 2015)
Kobe 1995 (Takegami 2015)
Irpinia & Naples 1980 (ISS 1981)
Niigata 2004 (Nakagawa 2009)
Niigata 2004 (Nakagawa 2009)
Great East Japan 2011 (Takegami 2015)
Niigata 2004 (Nakagawa 2009)
Kobe 1995 (Takegami 2015)
Irpinia & Naples 1980 (ISS 1981)
Niigata 2004 (Nakagawa 2009)
Great East Japan 2011 (Takegami 2015)
Niigata 2004 (Nakagawa 2009)
Kobe 1995 (Takegami 2015)
Irpinia & Naples 1980 (ISS 1981)
Niigata 2004 (Nakagawa 2009)
Great East Japan 2011 (Takegami 2015)
Niigata 2004 (Nakagawa 2009)
Kobe 1995 (Takegami 2015)
Irpinia & Naples 1980 (ISS 1981)
Niigata 2004 (Nakagawa 2009)
Great East Japan 2011 (Takegami 2015)
Niigata 2004 (Nakagawa 2009)
Kobe 1995 (Takegami 2015)
Niigata 2004 (Nakagawa 2009)
Irpinia & Naples 1980 (ISS 1981)
Great East Japan 2011 (Takegami 2015)
Niigata 2004 (Nakagawa 2009)
Kobe 1995 (Takegami 2015)
Irpinia & Naples 1980 (ISS 1981)
Niigata 2004 (Nakagawa 2009)
1.39 [1.31, 1.47]
1.57 [1.51, 1.63]
1.38 [1.14, 1.67]
1.14 [1.06, 1.23]
1.27 [1.18, 1.36]
1.39 [1.31, 1.47]
1.14 [1.06, 1.23]
1.57 [1.51, 1.63]
1.38 [1.14, 1.67]
1.27 [1.18, 1.36]
1.39 [1.31, 1.47]
1.14 [1.06, 1.23]
1.57 [1.51, 1.63]
1.38 [1.14, 1.67]
1.27 [1.18, 1.36]
1.39 [1.31, 1.47]
1.14 [1.06, 1.23]
1.57 [1.51, 1.63]
1.38 [1.14, 1.67]
1.27 [1.18, 1.36]
1.39 [1.31, 1.47]
1.14 [1.06, 1.23]
1.57 [1.51, 1.63]
1.27 [1.18, 1.36]
1.38 [1.14, 1.67]
1.39 [1.31, 1.47]
1.14 [1.06, 1.23]
1.57 [1.51, 1.63]
1.38 [1.14, 1.67]
1.27 [1.18, 1.36]
Main analysis: All studies (geographical comparison)
Main analysis: All studies (temporal comparison)
Sensitivity analysis: Follow-up duration < 6 months (temporal comparison)
Sensitivity analysis: Follow-up duration >= 6 months (geographical comparison)
Sensitivity analysis: Follow-up duration >= 6 months (temporal comparison)
Sensitivity analysis: % males not specified (geographical comparison)
Sensitivity analysis: % males not specified (temporal comparison)
Sensitivity analysis: Mean age not specified (geographical comparison)
Sensitivity analysis: Mean age not specified (temporal comparison)
Sensitivity analysis: General population (geographical comparison)
Sensitivity analysis: General population (temporal comparison)
Sensitivity analysis: Cross sectional (geographical comparison)
Sensitivity analysis: Cross sectional (temporal comparison)
Sensitivity analysis: Time series (temporal comparison)
1.36 [1.19, 1.57]RE model (Heterog. p-value=4.0059e-12; I²=94.0%)
1.36 [1.13, 1.63]RE model (Heterog. p-value=7.4630e-13; I²=96.9%)
1.36 [1.19, 1.57]RE model (Heterog. p-value=4.0059e-12; I²=94.0%)
1.36 [1.19, 1.57]RE model (Heterog. p-value=4.0059e-12; I²=94.0%)
1.36 [1.19, 1.57]RE model (Heterog. p-value=4.0059e-12; I²=94.0%)
1.46 [1.33, 1.61]RE model (Heterog. p-value=0.0016; I²=81.6%)
36 Cross sectional 1,074/1,991,109 2,254/5,287,968
3 Time series 381/325,295 149/175,925
12 Time series 6,800/16,545,012 4,331/16,545,012
36 Cross sectional 1,074/1,991,109 1,608/3,401,255
12 Time series 2,799/5,771,134 2,014/5,771,134
3 Time series 381/325,295 149/175,925
36 Cross sectional 1,074/1,991,109 2,254/5,287,968
12 Time series 6,800/16,545,012 4,331/16,545,012
36 Cross sectional 1,074/1,991,109 1,608/3,401,255
12 Time series 2,799/5,771,134 2,014/5,771,134
36 Cross sectional 1,074/1,991,109 2,254/5,287,968
3 Time series 381/325,295 149/175,925
12 Time series 6,800/16,545,012 4,331/16,545,012
36 Cross sectional 1,074/1,991,109 1,608/3,401,255
12 Time series 2,799/5,771,134 2,014/5,771,134
36 Cross sectional 1,074/1,991,109 2,254/5,287,968
3 Time series 381/325,295 149/175,925
12 Time series 6,800/16,545,012 4,331/16,545,012
36 Cross sectional 1,074/1,991,109 1,608/3,401,255
12 Time series 2,799/5,771,134 2,014/5,771,134
36 Cross sectional 1,074/1,991,109 2,254/5,287,968
3 Time series 381/325,295 149/175,925
12 Time series 6,800/16,545,012 4,331/16,545,012
36 Cross sectional 1,074/1,991,109 1,608/3,401,255
12 Time series 2,799/5,771,134 2,014/5,771,134
36 Cross sectional 1,074/1,991,109 2,254/5,287,968
36 Cross sectional 1,074/1,991,109 1,608/3,401,255
3 Time series 381/325,295 149/175,925
12 Time series 6,800/16,545,012 4,331/16,545,012
12 Time series 2,799/5,771,134 2,014/5,771,134
Follow-up
(months) Study design
Exposed
Events/Person-years
Unexposed
Events/Person-years
Myocardial infarction mortality
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0.20 0.40 0.80 1.40
Incidence Rate Ratio (95% CI)
Niigata 2004 (Hyodo 2010)
Kobe 1995 (Nishio 2009)
Los Angeles 1994 (Bourque 2002)
Irpinia & Naples 1980 (Alexander 1982)
Niigata 2004 (Hyodo 2010)
Niigata 2004 (Hyodo 2010)
Kobe 1995 (Nishio 2009)
Los Angeles 1994 (Bourque 2002)
Irpinia & Naples 1980 (Alexander 1982)
Niigata 2004 (Hyodo 2010)
Niigata 2004 (Hyodo 2010)
Kobe 1995 (Nishio 2009)
Los Angeles 1994 (Bourque 2002)
Irpinia & Naples 1980 (Alexander 1982)
Niigata 2004 (Hyodo 2010)
Kobe 1995 (Nishio 2009)
Los Angeles 1994 (Bourque 2002)
Irpinia & Naples 1980 (Alexander 1982)
Niigata 2004 (Hyodo 2010)
Niigata 2004 (Hyodo 2010)
Niigata 2004 (Hyodo 2010)
Kobe 1995 (Nishio 2009)
Los Angeles 1994 (Bourque 2002)
Niigata 2004 (Hyodo 2010)
Irpinia & Naples 1980 (Alexander 1982)
Niigata 2004 (Hyodo 2010)
Kobe 1995 (Nishio 2009)
Los Angeles 1994 (Bourque 2002)
Irpinia & Naples 1980 (Alexander 1982)
Niigata 2004 (Hyodo 2010)
1.03 [0.88, 1.20]
0.91 [0.77, 1.08]
0.86 [0.78, 0.93]
0.57 [0.36, 0.89]
1.08 [0.99, 1.19]
1.03 [0.88, 1.20]
0.91 [0.77, 1.08]
0.86 [0.78, 0.93]
0.57 [0.36, 0.89]
1.08 [0.99, 1.19]
1.03 [0.88, 1.20]
0.91 [0.77, 1.08]
0.86 [0.78, 0.93]
0.57 [0.36, 0.89]
1.08 [0.99, 1.19]
0.91 [0.77, 1.08]
0.86 [0.78, 0.93]
0.57 [0.36, 0.89]
1.03 [0.88, 1.20]
1.08 [0.99, 1.19]
1.03 [0.88, 1.20]
0.91 [0.77, 1.08]
0.86 [0.78, 0.93]
1.08 [0.99, 1.19]
0.57 [0.36, 0.89]
1.03 [0.88, 1.20]
0.91 [0.77, 1.08]
0.86 [0.78, 0.93]
0.57 [0.36, 0.89]
1.08 [0.99, 1.19]
Main analysis: All studies (geographical comparison)
Main analysis: All studies (temporal comparison)
Sensitivity analysis: Follow-up duration < 6 months (temporal comparison)
Sensitivity analysis: Follow-up duration >= 6 months (geographical comparison)
Sensitivity analysis: Follow-up duration >= 6 months (temporal comparison)
Sensitivity analysis: % males < 50% (geographical comparison)
Sensitivity analysis: % males < 50% (temporal comparison)
Sensitivity analysis: % males not specified (temporal comparison)
Sensitivity analysis: Mean age not specified (geographical comparison)
Sensitivity analysis: Mean age not specified (temporal comparison)
Sensitivity analysis: General population (geographical comparison)
Sensitivity analysis: General population (temporal comparison)
Sensitivity analysis: Time series (geographical comparison)
Sensitivity analysis: Time series (temporal comparison)
0.89 [0.79, 1.01]RE model (Heterog. p-value=0.0428; I²=56.7%)
0.92 [0.82, 1.03]RE model (Heterog. p-value=0.1208; I²=52.5%)
0.86 [0.79, 0.93]RE model (Heterog. p-value=0.1514; I²=0.1%)
0.89 [0.79, 1.01]RE model (Heterog. p-value=0.0428; I²=56.7%)
0.89 [0.79, 1.01]RE model (Heterog. p-value=0.0428; I²=56.7%)
0.89 [0.79, 1.01]RE model (Heterog. p-value=0.0428; I²=56.7%)
36 Time series 648/1,991,109 1,589/5,287,968
3 Time series 21/1,514,606 245/10,055,493
12 Time series 906/7,676,512 1,059/7,676,512
36 Time series 500/3,655,863 191/1,273,333
36 Time series 648/1,991,109 215/680,251
3 Time series 21/1,514,606 245/10,055,493
36 Time series 648/1,991,109 1,589/5,287,968
12 Time series 906/7,676,512 1,059/7,676,512
36 Time series 500/3,655,863 191/1,273,333
36 Time series 648/1,991,109 215/680,251
36 Time series 648/1,991,109 1,589/5,287,968
36 Time series 648/1,991,109 215/680,251
3 Time series 21/1,514,606 245/10,055,493
12 Time series 906/7,676,512 1,059/7,676,512
36 Time series 500/3,655,863 191/1,273,333
36 Time series 648/1,991,109 1,589/5,287,968
3 Time series 21/1,514,606 245/10,055,493
12 Time series 906/7,676,512 1,059/7,676,512
36 Time series 500/3,655,863 191/1,273,333
36 Time series 648/1,991,109 215/680,251
36 Time series 648/1,991,109 1,589/5,287,968
3 Time series 21/1,514,606 245/10,055,493
12 Time series 906/7,676,512 1,059/7,676,512
36 Time series 500/3,655,863 191/1,273,333
36 Time series 648/1,991,109 215/680,251
36 Time series 648/1,991,109 1,589/5,287,968
3 Time series 21/1,514,606 245/10,055,493
12 Time series 906/7,676,512 1,059/7,676,512
36 Time series 500/3,655,863 191/1,273,333
36 Time series 648/1,991,109 215/680,251
Follow-up
(months) Study design
Exposed
Events/Person-years
Unexposed
Events/Person-years
Suicides
Supplementary Materials 3. Sensitivity analyses for meta-analyses with 4 or more studies
Page 8 of 9
-50.00 0.00 50.00 100.00
Mean Difference (95% CI)
Great East Japan 2011 (Fujihara 2012)
Niigata 2004 (Kamoi 2006b)
Niigata 2004 (Kamoi 2006a)
Irpinia & Naples 1980 (Trevisan 1992)
Great East Japan 2011 (Fujihara 2012)
Niigata 2004 (Kamoi 2006b)
Niigata 2004 (Kamoi 2006a)
Irpinia & Naples 1980 (Trevisan 1992)
Great East Japan 2011 (Fujihara 2012)
Niigata 2004 (Kamoi 2006b)
Niigata 2004 (Kamoi 2006a)
Irpinia & Naples 1980 (Trevisan 1992)
Great East Japan 2011 (Fujihara 2012)
Niigata 2004 (Kamoi 2006a)
Irpinia & Naples 1980 (Trevisan 1992)
Niigata 2004 (Kamoi 2006b)
Niigata 2004 (Kamoi 2006b)
Niigata 2004 (Kamoi 2006a)
Irpinia & Naples 1980 (Trevisan 1992)
Great East Japan 2011 (Fujihara 2012)
Niigata 2004 (Kamoi 2006b)
Niigata 2004 (Kamoi 2006a)
Irpinia & Naples 1980 (Trevisan 1992)
Great East Japan 2011 (Fujihara 2012)
Niigata 2004 (Kamoi 2006b)
Niigata 2004 (Kamoi 2006a)
Irpinia & Naples 1980 (Trevisan 1992)
  1.77 [-10.16, 13.70]
  9.00 [ -8.10, 26.10]
-19.69 [-36.12, -3.27]
  6.08 [-11.94, 24.09]
  1.77 [-10.16, 13.70]
  9.00 [ -8.10, 26.10]
-19.69 [-36.12, -3.27]
  6.08 [-11.94, 24.09]
  1.77 [-10.16, 13.70]
  9.00 [ -8.10, 26.10]
-19.69 [-36.12, -3.27]
  6.08 [-11.94, 24.09]
  1.77 [-10.16, 13.70]
-19.69 [-36.12, -3.27]
  6.08 [-11.94, 24.09]
  9.00 [ -8.10, 26.10]
  9.00 [ -8.10, 26.10]
-19.69 [-36.12, -3.27]
  6.08 [-11.94, 24.09]
  1.77 [-10.16, 13.70]
  0.00 [-14.44, 14.44]
-13.46 [-29.79,  2.87]
 30.90 [ 10.59, 51.21]
  1.77 [-10.16, 13.70]
  9.00 [ -8.10, 26.10]
-19.69 [-36.12, -3.27]
  6.08 [-11.94, 24.09]
Main analysis: All studies (temporal comparison)
Sensitivity analysis: Follow-up duration < 6 months (temporal comparison)
Sensitivity analysis: Follow-up duration >= 6 months (temporal comparison)
Sensitivity analysis: % males < 50% (temporal comparison)
Sensitivity analysis: % males >= 50% (temporal comparison)
Sensitivity analysis: Mean age < 50 years (temporal comparison)
Sensitivity analysis: Mean age >= 50 years (temporal comparison)
Sensitivity analysis: Occupational subgroups (temporal comparison)
Sensitivity analysis: Patient subgroups (temporal comparison)
Sensitivity analysis: Cohort (temporal comparison)
-0.77 [-12.98, 11.44]RE model (Heterog. p-value=0.0694; I²=58.8%)
3.91 [-12.78, 20.61]RE model (Heterog. p-value=0.0102; I²=78.8%)
-1.76 [-19.89, 16.36]RE model (Heterog. p-value=0.0331; I²=70.1%)
-3.78 [-18.75, 11.19]RE model (Heterog. p-value=0.0622; I²=65.1%)
-2.80 [-18.90, 13.30]RE model (Heterog. p-value=0.0402; I²=70.8%)
-2.80 [-18.90, 13.30]RE model (Heterog. p-value=0.0402; I²=70.8%)
-0.77 [-12.98, 11.44]RE model (Heterog. p-value=0.0694; I²=58.8%)
79 Cohort 102 505 133.6 (86.74) 127.5 (73.70) mg/dL
6 Cohort 222 222 125.3 (69.14) 145.0 (104.00) mg/dL
12 Cohort 64 65 96.0 (56.00) 87.0 (42.00) mg/dL
3 Cohort 320 320 132.9 (77.82) 131.1 (76.17) mg/dL
2 Cohort 102 505 158.4 (99.30) 127.5 (73.70) mg/dL
3 Cohort 222 222 131.5 (67.78) 145.0 (104.00) mg/dL
3 Cohort 65 65 87.0 (42.00) 87.0 (42.00) mg/dL
3 Cohort 320 320 132.9 (77.82) 131.1 (76.17) mg/dL
79 Cohort 102 505 133.6 (86.74) 127.5 (73.70) mg/dL
6 Cohort 222 222 125.3 (69.14) 145.0 (104.00) mg/dL
12 Cohort 64 65 96.0 (56.00) 87.0 (42.00) mg/dL
12 Cohort 64 65 96.0 (56.00) 87.0 (42.00) mg/dL
79 Cohort 102 505 133.6 (86.74) 127.5 (73.70) mg/dL
6 Cohort 222 222 125.3 (69.14) 145.0 (104.00) mg/dL
3 Cohort 320 320 132.9 (77.82) 131.1 (76.17) mg/dL
79 Cohort 102 505 133.6 (86.74) 127.5 (73.70) mg/dL
6 Cohort 222 222 125.3 (69.14) 145.0 (104.00) mg/dL
12 Cohort 64 65 96.0 (56.00) 87.0 (42.00) mg/dL
3 Cohort 320 320 132.9 (77.82) 131.1 (76.17) mg/dL
79 Cohort 102 505 133.6 (86.74) 127.5 (73.70) mg/dL
6 Cohort 222 222 125.3 (69.14) 145.0 (104.00) mg/dL
12 Cohort 64 65 96.0 (56.00) 87.0 (42.00) mg/dL
3 Cohort 320 320 132.9 (77.82) 131.1 (76.17) mg/dL
79 Cohort 102 505 133.6 (86.74) 127.5 (73.70) mg/dL
6 Cohort 222 222 125.3 (69.14) 145.0 (104.00) mg/dL
12 Cohort 64 65 96.0 (56.00) 87.0 (42.00) mg/dL
3 Cohort 320 320 132.9 (77.82) 131.1 (76.17) mg/dL
Follow-up
(months) Study design
Exposed
Participants
Unexposed
Participants
Exposed
Mean (SD)
Unexposed
Mean (SD) Unit
Triglycerides
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0.20 1.00 30.00
Incidence Rate Ratio (95% CI)
Stroke mortality
Renal mortality
Myocardial infarction mortality
Myocardial infarction mortality (including sudden death)
Myocardial infarction mortality
Death for coronary heart disease, including sudden death
Death for cardiocirculatory cause
Death for cardiocirculatory cause (onset < 1 week)
All-cause mortality
All-cause mortality
1.37 [1.29,  1.46]
0.91 [0.25,  3.40]
1.36 [1.19,  1.57]
0.68 [0.51,  0.89]
1.27 [1.18,  1.36]
4.67 [1.93, 11.27]
1.39 [1.28,  1.50]
1.43 [1.30,  1.58]
1.02 [1.01,  1.03]
2.29 [0.21, 25.21]Geographical 36 1 2/42 1/48 - 0.4997
Temporal 12 2 179,502/22,316,146 176,741/22,316,146 49.9% 0.0009
Temporal 3 1 1,482/325,295 560/175,925 - 4.8991e-13
Temporal 3 1 2,167/325,295 845/175,925 - 7.3359e-16
Temporal 3 1 28/18,071 6/18,071 - 0.0006
Geographical 36 1 1,074/1,991,109 2,254/5,287,968 - 2.1597e-10
Temporal 4 1 58/142,933 334/557,200 - 0.0061
Temporal 3 to 36 4 11,054/24,632,550 8,102/25,893,326 94.0% 1.2610e-05
Geographical 36 1 4/42 5/48 - 0.8937
Temporal 12 2 24,429/22,316,146 17,987/22,316,146 89.6% 3.5259e-22
Comparison
Follow-up
(months) Studies
Exposed
Events/Person-years
Unexposed
Events/Person-years I²
Effect
p-value
Mortality
Supplementary Materials 4. Full results of all earthquake effects
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0.53 150.00
Incidence Rate Ratio (95% CI)
Ventricular arrhythmia
Supraventricular tachycardia and ventricular arrhythmia
Stress cardiomyopathy
Myocardial infarction
Myocardial infarction, possible, nonfatal
Coronary heart disease
Cerebrovascular disease
Atrial fibrillation
Acute admissions to cardiology department
 0.85 [0.68,   1.07]
 0.81 [0.64,   1.02]
14.43 [1.94, 107.48]
 1.01 [0.54,   1.92]
 0.99 [0.81,   1.21]
 1.36 [0.82,   2.25]
 0.97 [0.78,   1.21]
 1.41 [0.92,   2.16]
 1.07 [0.96,   1.20]Temporal 1 2 834/71,371 468/42,909 0.0% 0.2332
Temporal 1 2 46/20 38/23 0.0% 0.1191
Temporal 4 1 148/31,491 158/32,607 - 0.7894
Temporal 1 to 4 2 350/34,751 299/42,399 27.9% 0.2336
Temporal 4 1 122/142,933 480/557,200 - 0.9276
Temporal 3 to 4 2 128/161,004 460/575,271 83.9% 0.9641
Temporal 1 2 27/71,371 0/42,909 0.0% 0.0092
Temporal 6 1 126/85 156/85 - 0.0746
Temporal 6 1 138/85 162/85 - 0.1663
Comparison
Follow-up
(months) Studies
Exposed
Events/Person-years
Unexposed
Events/Person-years I²
Effect
p-value
Diseases of the circulatory system (Incidence Rate Ratio)
Supplementary Materials 4. Full results of all earthquake effects
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-10.00 0.00 10.00 20.00
Mean Difference (95% CI)
Morning home systolic blood pressure
Morning home diastolic blood pressure
Clinically measured systolic blood pressure
Clinically measured diastolic blood pressure
Aortic diameter, maximum
 2.84 [ 0.61,  5.07]
-0.93 [-2.72,  0.86]
-1.86 [-5.35,  1.64]
-0.91 [-5.06,  3.24]
12.70 [ 9.06, 16.34]mm Temporal 2 1 5 5 - 7.5214e-12
mmHg Temporal 2 to 79 7 5,568 5,476 98.2% 0.6670
mmHg Temporal 2 to 79 7 5,568 5,476 93.7% 0.2978
mmHg Temporal 1 to 6 2 247 247 0.0% 0.3102
mmHg Temporal 1 to 6 2 247 247 0.0% 0.0127
Unit Comparison
Follow-up
(months) Studies
Exposed
Participants
Unexposed
Participants I²
Effect
p-value
Diseases of the circulatory system (Mean Difference)
Supplementary Materials 4. Full results of all earthquake effects
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0.47 1.00 2.50
Risk Ratio (95% CI)
Coronary heart disease 1.00 [0.47, 2.11]Temporal 6 1 13/222 13/222 - 1.0000
Comparison
Follow-up
(months) Studies
Exposed
Events/Participants
Unexposed
Events/Participants I²
Effect
p-value
Diseases of the circulatory system (Risk Ratio)
Supplementary Materials 4. Full results of all earthquake effects
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0.06 1.00 80.00
Risk Ratio (95% CI)
Diabetes complications, retinopathy
Diabetes complications, others
Diabetes complications, neuropathy
Diabetes complications, nephropathy
1.01 [0.77,  1.31]
3.05 [0.13, 73.41]
1.01 [0.06, 16.00]
1.08 [0.84,  1.39]Temporal 6 to 12 2 86/286 80/287 0.0% 0.5591
Temporal 6 to 12 2 0/286 0/287 0.0% 0.9957
Temporal 12 1 1/64 0/65 - 0.4927
Temporal 6 to 12 2 79/286 79/287 0.0% 0.9663
Comparison
Follow-up
(months) Studies
Exposed
Events/Participants
Unexposed
Events/Participants I²
Effect
p-value
Endocrine, nutritional and metabolic diseases
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0.46 1.00 8.00
Incidence Rate Ratio (95% CI)
Stroke
Stroke, ischaemic
Stroke, haemorrhagic
0.99 [0.75, 1.31]
1.07 [0.77, 1.49]
1.68 [0.46, 6.08]Temporal 1 to 24 2 32/20,863 20/18,550 77.8% 0.4307
Temporal 1 to 24 3 236/103,248 183/94,576 62.1% 0.6834
Temporal 1 to 24 3 295/103,248 245/94,576 60.8% 0.9446
Comparison
Follow-up
(months) Studies
Exposed
Events/Person-years
Unexposed
Events/Person-years I²
Effect
p-value
Diseases of the nervous system (Incidence Rate Ratio)
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0.50 1.00 1.50
Risk Ratio (95% CI)
Stroke 1.00 [0.54, 1.84]Temporal 6 1 19/222 19/222 - 1.0000
Comparison
Follow-up
(months) Studies
Exposed
Events/Participants
Unexposed
Events/Participants I²
Effect
p-value
Diseases of the nervous system (Risk Ratio)
Supplementary Materials 4. Full results of all earthquake effects
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0.01 1.00 80.00
Incidence Rate Ratio (95% CI)
Suicides
Suicides
Suicides, attempted
Psychiatric emergency hospitalization
Psychiatric emergency hospitalization, schizophrenia
Psychiatric emergency hospitalization, schizophrenia/schizotypal/delusional disorders
Psychiatric emergency hospitalization, organic mental disorders
Psychiatric emergency hospitalization, neurotic/stress-related/somatoform disorders
Psychiatric emergency hospitalization, mood/affective disorders
Psychiatric emergency hospitalization, mental retardation
Psychiatric emergency hospitalization, mental disorders due to psychoactive substance use
Psychiatric emergency hospitalization, disorders of psychological development
Psychiatric emergency hospitalization, disorders of adult personality and behaviour
Psychiatric emergency hospitalization, behavioural syndromes associated with physiological disturbances and physical factors
Psychiatric emergency hospitalization, behavioural and emotional disorders with onset usually occurring in childhood and adolescence
Psychiatric emergency hospitalization, acute transient psychotic disorders
0.89 [0.79,  1.01]
1.08 [0.99,  1.19]
1.06 [0.91,  1.23]
1.29 [0.99,  1.67]
1.72 [1.11,  2.65]
1.69 [1.17,  2.43]
0.49 [0.09,  2.68]
1.31 [0.45,  3.77]
1.08 [0.46,  2.54]
0.20 [0.02,  1.68]
0.33 [0.12,  0.90]
2.95 [0.12, 72.32]
1.96 [0.92,  4.20]
0.33 [0.01,  8.04]
0.98 [0.02, 49.49]
1.72 [0.85,  3.49]Temporal 6 1 21/2,217,410 12/2,177,472 - 0.1346
Temporal 6 1 0/2,217,410 0/2,177,472 - 0.9927
Temporal 6 1 0/2,217,410 1/2,177,472 - 0.4940
Temporal 6 1 20/2,217,410 10/2,177,472 - 0.0814
Temporal 6 1 1/2,217,410 0/2,177,472 - 0.5082
Temporal 6 1 5/2,217,410 15/2,177,472 - 0.0306
Temporal 6 1 1/2,217,410 5/2,177,472 - 0.1373
Temporal 6 1 11/2,217,410 10/2,177,472 - 0.8599
Temporal 6 1 8/2,217,410 6/2,177,472 - 0.6178
Temporal 6 1 2/2,217,410 4/2,177,472 - 0.4114
Temporal 6 1 79/2,217,410 46/2,177,472 - 0.0048
Temporal 6 1 56/2,217,410 32/2,177,472 - 0.0146
Temporal 6 1 127/2,217,410 97/2,177,472 - 0.0624
Temporal 3 to 6 2 336/1,814,606 483/10,355,493 0.0% 0.4357
Geographical 36 1 648/1,991,109 1,589/5,287,968 - 0.0870
Temporal 3 to 36 4 2,075/14,838,090 1,710/19,685,589 56.7% 0.0725
Comparison
Follow-up
(months) Studies
Exposed
Events/Person-years
Unexposed
Events/Person-years I²
Effect
p-value
Mental, behavioral and neurodevelopmental disorders (Incidence Rate Ratio)
Supplementary Materials 4. Full results of all earthquake effects
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0.00 5.00 10.00 15.00
Mean Difference (95% CI)
Insomnia, average daily prevalence
Frequency of headaches
0.95 [0.93,  0.98]
7.80 [1.68, 13.92]days/month Temporal 4 1 12 16 - 0.0125
% Temporal 2 1 5,053 5,053 - 0.0000
Unit Comparison
Follow-up
(months) Studies
Exposed
Participants
Unexposed
Participants I²
Effect
p-value
Mental, behavioral and neurodevelopmental disorders (Mean Difference)
Supplementary Materials 4. Full results of all earthquake effects
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0.45 300.00
Risk Ratio (95% CI)
Suicides, attempted or ideated
Suicides, attempted
Post-traumatic stress disorder, probable
Post-traumatic stress disorder
Other anxiety disorder
Major depressive disorder, probable
Major depressive disorder, probable
Major depressive disorder
Generalized anxiety disorder, probable
Acute stress disorder, probable
 2.56 [1.37,   4.81]
 2.45 [0.45,  13.32]
14.15 [0.87, 230.62]
 1.61 [0.66,   3.92]
 1.28 [0.92,   1.80]
 1.56 [1.07,   2.29]
 2.39 [1.35,   4.24]
 1.32 [0.89,   1.94]
 1.94 [0.89,   4.24]
 1.58 [0.92,   2.74]Geographical 2 1 23/61 15/63 - 0.0995
Geographical 2 1 15/61 8/63 - 0.0979
Geographical 24 1 63/543 36/409 - 0.1639
Geographical 2 to 6 2 52/176 13/111 0.0% 0.0028
Temporal 19 1 147/936 28/279 - 0.0214
Geographical 24 1 80/543 47/409 - 0.1479
Geographical 24 1 15/543 7/409 - 0.2906
Geographical 3 1 12/52 0/29 - 0.0628
Geographical 12 1 4/426 2/522 - 0.2993
Geographical 12 to 24 2 36/969 14/931 5.6% 0.0034
Comparison
Follow-up
(months) Studies
Exposed
Events/Participants
Unexposed
Events/Participants I²
Effect
p-value
Mental, behavioral and neurodevelopmental disorders (Risk Ratio)
Supplementary Materials 4. Full results of all earthquake effects
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0.60 10.00
Incidence Rate Ratio (95% CI)
Gastric ulcer, with serum H. Pylori IgG
Gastric ulcer, with bleeding
Gastric ulcer, with bleeding
Gastric ulcer
Gastric ulcer
Gastric and duodenal ulcer
Gastric and duodenal ulcer
Duodenal ulcer, with serum H. Pylori IgG
Duodenal ulcer, with bleeding
Duodenal ulcer, with bleeding
Duodenal ulcer
Duodenal ulcer
1.06 [0.82, 1.38]
3.22 [2.49, 4.18]
5.57 [3.51, 8.83]
1.57 [1.43, 1.72]
1.36 [1.16, 1.59]
1.49 [0.86, 2.56]
1.53 [0.60, 3.88]
1.04 [0.67, 1.59]
2.15 [1.34, 3.46]
3.88 [1.55, 9.71]
1.14 [1.00, 1.31]
1.09 [0.84, 1.40]Geographical 2 1 109/466 123/571 - 0.5322
Temporal 2 1 358/1,666 465/2,477 - 0.0550
Geographical 2 1 19/466 6/571 - 0.0038
Temporal 2 1 42/1,666 29/2,477 - 0.0015
Geographical 2 1 33/6 57/10 - 0.8715
Geographical 2 1 10/466 8/571 - 0.3690
Temporal 2 1 26/1,666 26/2,477 - 0.1529
Geographical 2 1 335/466 302/571 - 0.0001
Temporal 2 1 960/1,666 909/2,477 - 1.9366e-22
Geographical 2 1 100/466 22/571 - 3.0579e-13
Temporal 2 1 180/1,666 83/2,477 - 1.1222e-18
Geographical 2 1 99/19 140/28 - 0.6385
Comparison
Follow-up
(months) Studies
Exposed
Events/Person-years
Unexposed
Events/Person-years I²
Effect
p-value
Diseases of the digestive system
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0.49 250.00
Risk Ratio (95% CI)
Upper respitatory tract inflammation, as initial symptom
Pulmonary haemorrhage
Interstitial pneumonitis
 4.57 [1.16,  18.05]
12.47 [0.75, 207.19]
 2.29 [0.49,  10.64]Geographical 36 1 4/14 2/16 - 0.2922
Geographical 36 1 5/14 0/16 - 0.0785
Geographical 36 1 8/14 2/16 - 0.0301
Comparison
Follow-up
(months) Studies
Exposed
Events/Participants
Unexposed
Events/Participants I²
Effect
p-value
Diseases of the respiratory system
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0.01 1.00 200.00
Incidence Rate Ratio (95% CI)
Whooping cough (pertussis)
Viral neuritis
Viral hepatitis
Typhoid fever
Tuberculosis: pulmonary
Tuberculosis: extra-pulmonary
Tetanus
Scarlettina (Scarlet fever)
Roseola infantum
Poliomyelitis
Pneumococcal pneumonia
Paratyphoid and other salmonellosis
Meningococcal meningitis
Leptospirosis
German measles
Endemic parotitis (Mumps)
Dyphtheria
Chicken pox (Varicella)
Brucellosis
Botulism
Blennorrhoea
Bacillary dysentery
 0.05 [0.02,   0.09]
10.95 [0.61, 198.11]
 1.51 [1.44,   1.58]
 1.26 [1.15,   1.38]
 1.73 [0.98,   3.04]
 1.00 [0.02,  50.19]
 1.99 [0.18,  21.96]
 0.66 [0.11,   3.97]
 0.66 [0.24,   1.87]
 1.00 [0.02,  50.19]
 1.17 [0.78,   1.74]
 1.38 [1.21,   1.57]
 1.18 [0.84,   1.64]
 1.00 [0.02,  50.19]
 0.09 [0.05,   0.17]
 1.44 [1.00,   2.08]
 0.60 [0.24,   1.49]
 1.19 [0.96,   1.46]
 0.84 [0.50,   1.40]
 0.20 [0.01,   4.15]
 0.20 [0.02,   1.70]
 2.99 [0.12,  73.34]Temporal 2 1 1/1,009,738 0/1,005,549 - 0.5027
Temporal 2 1 1/1,009,738 5/1,005,549 - 0.1408
Temporal 2 1 0/1,009,738 2/1,005,549 - 0.2976
Temporal 2 1 27/1,009,738 32/1,005,549 - 0.5054
Temporal 2 1 192/1,009,738 161/1,005,549 - 0.1076
Temporal 7 1 6/2,813,615 20/5,627,230 - 0.2725
Temporal 2 1 71/1,009,738 49/1,005,549 - 0.0483
Temporal 2 1 12/1,009,738 760/6,000,386 - 4.1854e-16
Temporal 2 1 0/1,009,738 0/1,005,549 - 0.9983
Temporal 7 1 45/3,534,082 146/13,500,868 - 0.3380
Temporal 7 1 377/2,813,615 548/5,627,230 - 1.8501e-06
Temporal 16 1 44/495,339 53/697,974 - 0.4419
Temporal 2 1 0/1,009,738 0/1,005,549 - 0.9983
Temporal 2 1 6/1,009,738 9/1,005,549 - 0.4370
Temporal 2 1 2/1,009,738 3/1,005,549 - 0.6536
Temporal 2 1 2/1,009,738 1/1,005,549 - 0.5737
Temporal 2 1 0/1,009,738 0/1,005,549 - 0.9983
Temporal 2 1 33/1,009,738 19/1,005,549 - 0.0571
Temporal 7 1 599/2,411,670 2,217/11,254,460 - 4.8112e-07
Temporal 7 1 2,511/2,411,670 7,753/11,254,460 - 2.3910e-72
Temporal 2 1 5/1,009,738 0/1,005,549 - 0.1051
Temporal 2 1 9/1,009,738 1,141/6,000,386 - 5.9679e-20
Comparison
Follow-up
(months) Studies
Exposed
Events/Person-years
Unexposed
Events/Person-years I²
Effect
p-value
Infectious and parasitic diseases
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-0.15 -0.05 0.05
Mean Difference (95% CI)
Gestational age -0.03 [-0.11, 0.05]weeks Temporal 9 1 3,447 3,427 - 0.4788
Unit Comparison
Follow-up
(months) Studies
Exposed
Participants
Unexposed
Participants I²
Effect
p-value
Pregnancy, childbirth and the puerperium (Mean Difference)
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0.80 0.90 1.00 1.20
Risk Ratio (95% CI)
Preterm
Male newborns
Male newborns
All newborns (fertility)
1.02 [0.84, 1.23]
0.97 [0.94, 1.00]
0.98 [0.94, 1.03]
0.98 [0.96, 1.00]Temporal 9 1 17,411/5,395,158 17,695/5,395,158 - 0.1290
Geographical 9 1 1,737/3,447 1,837/3,588 - 0.4987
Temporal 9 2 3,705/7,375 3,942/7,627 0.0% 0.0755
Temporal 9 1 200/3,447 195/3,427 - 0.8418
Comparison
Follow-up
(months) Studies
Exposed
Events/Participants
Unexposed
Events/Participants I²
Effect
p-value
Pregnancy, childbirth and the puerperium (Risk Ratio)
Supplementary Materials 4. Full results of all earthquake effects
Page 15 of 50
1.00 15.00
Incidence Rate Ratio (95% CI)
Recurrence of endogenous uveitis 3.62 [1.02, 12.83]Temporal 6 1 12/58 3/52 - 0.0462
Comparison
Follow-up
(months) Studies
Exposed
Events/Person-years
Unexposed
Events/Person-years I²
Effect
p-value
Other diseases (Incidence Rate Ratio)
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0.19 1.00 3.00
Risk Ratio (95% CI)
Renal failure, no recover after haemodialisis 0.69 [0.20, 2.37]Geographical 36 1 3/14 5/16 - 0.5505
Comparison
Follow-up
(months) Studies
Exposed
Events/Participants
Unexposed
Events/Participants I²
Effect
p-value
Other diseases (Risk Ratio)
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-10.00 0.00 10.00 30.00
Mean Difference (95% CI)
Unhealthy days, continuous
Cornell Medical Index, somatic status score
Cornell Medical Index, emotion status score
 0.22 [-0.95,  1.39]
 3.64 [-5.70, 12.98]
11.50 [ 0.01, 22.99]- Temporal 3 1 14 15 - 0.0498
- Temporal 3 1 14 15 - 0.4449
days Temporal 19 1 957 283 - 0.7087
Unit Comparison
Follow-up
(months) Studies
Exposed
Participants
Unexposed
Participants I²
Effect
p-value
Health status and quality of life (Mean Difference)
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0.74 6.00
Risk Ratio (95% CI)
Health status, low physical, binary
Health status, low mental, binary
Health status, low, binary
Health status, functional limitations, binary
1.27 [0.77, 2.08]
1.14 [0.79, 1.64]
0.88 [0.74, 1.05]
2.51 [1.09, 5.80]Temporal 19 1 51/957 6/283 - 0.0306
Temporal 19 1 322/957 108/283 - 0.1535
Temporal 19 1 123/957 32/283 - 0.4923
Temporal 19 1 77/957 18/283 - 0.3526
Comparison
Follow-up
(months) Studies
Exposed
Events/Participants
Unexposed
Events/Participants I²
Effect
p-value
Health status and quality of life (Risk Ratio)
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0.97 0.98 1.00
Incidence Rate Ratio (95% CI)
Hospital discharges 0.97 [0.97, 0.98]Temporal 6 1 399,263/3,029,213 948,532/7,000,450 - 1.4985e-48
Comparison
Follow-up
(months) Studies
Exposed
Events/Person-years
Unexposed
Events/Person-years I²
Effect
p-value
Healthcare quality and costs
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-20.00 0.00 10.00
Mean Difference (95% CI)
Weight
Cardiotoracic ratio
Body mass index
-0.02 [ -2.17,  2.12]
 0.30 [-11.65, 12.25]
-0.08 [ -0.23,  0.06]Kg/m² Temporal 3 to 79 5 4,743 5,147 3.2% 0.2675
% Temporal 2 1 25 25 - 0.9607
Kg Temporal 2 2 230 230 0.0% 0.9849
Unit Comparison
Follow-up
(months) Studies
Exposed
Participants
Unexposed
Participants I²
Effect
p-value
Vital signs (Mean Difference)
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0.50 1.00 1.50 2.50
Risk Ratio (95% CI)
Body mass index, underweight
Body mass index, overweight
Body mass index, obese
Body mass index, normal
1.11 [0.52, 2.40]
0.93 [0.77, 1.11]
1.00 [0.69, 1.45]
1.05 [0.92, 1.19]Temporal 19 1 504/950 143/282 - 0.4948
Temporal 19 1 108/950 32/282 - 0.9923
Temporal 19 1 309/950 99/282 - 0.4142
Temporal 19 1 30/950 8/282 - 0.7845
Comparison
Follow-up
(months) Studies
Exposed
Events/Participants
Unexposed
Events/Participants I²
Effect
p-value
Vital signs (Risk Ratio)
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-2000.00 2000.00 6000.00
Mean Difference (95% CI)
White blood cells
Uric acid
Urea
Urea nitrogen
Triglycerides
Total protein
Total cholesterol
Thyrotropin receptor antibody
Thyroid stimulating hormone
Thyroid stimulating antibody
Thyroid peroxidase antibody
Thyroglobulin antibody
Sodium
Potassium
Phosphorus
Myeloperoxidase-antineutrophil cytoplasmic autoantibody
LDL cholesterol
Heart rate
HDL cholesterol
Haemoglobin
Glycated haemoglobin
Glucose, plasma, random
Free T4
Free T3
Creatinine
Creatinine
Creatinine, declining rate of 1/Cr
C-reactive protein
Cortisol, salivary
Chloride
Calcium
Albumin
3205.00 [ 634.42, 5775.58]
   0.04 [  -0.19,    0.27]
   1.10 [  -1.65,    3.85]
  -0.90 [  -9.45,    7.65]
  -0.77 [ -12.98,   11.44]
   0.10 [   0.01,    0.19]
   0.83 [  -1.35,    3.02]
  -1.08 [ -11.48,    9.32]
  -0.39 [  -2.03,    1.24]
 -33.68 [ -97.50,   30.14]
-145.08 [-397.73,  107.57]
 -13.41 [-118.60,   91.79]
   0.00 [  -0.51,    0.51]
   0.10 [  -0.03,    0.23]
   0.20 [   0.01,    0.39]
  48.00 [-192.77,  288.77]
  -1.19 [  -4.42,    2.04]
  -0.92 [  -2.55,    0.71]
  -0.21 [  -1.01,    0.58]
  -0.19 [  -0.37,   -0.01]
   0.16 [   0.07,    0.25]
   0.53 [  -0.09,    1.15]
  -0.07 [  -0.22,    0.07]
  -0.04 [  -0.52,    0.43]
   0.00 [  -0.04,    0.04]
   5.30 [   3.19,    7.41]
   0.24 [   0.08,    0.40]
   7.00 [  -0.44,   14.44]
   7.54 [   3.86,   11.21]
   0.00 [  -0.59,    0.59]
  -0.09 [  -0.19,    0.01]
  -0.10 [  -0.38,    0.18]g/dL Temporal 2 1 25 25 - 0.4795
mg/dL Temporal 1 to 2 2 230 230 0.0% 0.0765
mEq/L Temporal 1 1 205 205 - 1.0000
- Temporal 3 1 28 30 - 5.8733e-05
mg/dL Geographical 36 1 14 16 - 0.0651
dL/mg/week Geographical 36 1 14 16 - 0.0042
mg/dL Geographical 36 1 14 16 - 8.0622e-07
mg/dL Temporal 1 to 6 3 452 452 0.0% 0.9887
pg/mL Temporal 2 1 207 207 - 0.8567
ng/mL Temporal 2 1 207 207 - 0.3250
mmol/L Temporal 3 1 320 320 - 0.0933
% Temporal 2 to 12 4 716 717 33.3% 0.0008
g/dL Temporal 1 to 2 2 230 230 0.0% 0.0352
mg/dL Temporal 3 to 14 4 4,641 4,642 5.8% 0.5993
beats/min Temporal 2 to 79 2 307 710 0.0% 0.2684
mg/dL Temporal 3 to 12 3 606 607 0.0% 0.4697
U/mL Geographical 36 1 14 16 - 0.6960
mg/dL Temporal 1 to 2 2 230 230 0.0% 0.0424
mEq/L Temporal 1 1 205 205 - 0.1204
mEq/L Temporal 1 1 205 205 - 1.0000
U/mL Temporal 2 1 138 138 - 0.8028
U/mL Temporal 2 1 138 138 - 0.2604
% Temporal 2 1 207 207 - 0.3010
μIU/mL Temporal 2 1 207 207 - 0.6377
IU/L Temporal 2 1 207 207 - 0.8392
mg/dL Temporal 3 to 79 5 4,743 5,147 21.9% 0.4537
g/dL Temporal 1 1 205 205 - 0.0360
mg/dL Temporal 3 to 79 4 708 1,112 58.8% 0.9014
mg/dL Temporal 2 1 25 25 - 0.8365
mg/dL Temporal 1 1 205 205 - 0.4329
mg/dL Temporal 1 to 14 2 4,240 4,240 68.1% 0.7469
count/µL Geographical 36 1 14 16 - 0.0145
Unit Comparison
Follow-up
(months) Studies
Exposed
Participants
Unexposed
Participants I²
Effect
p-value
Biomarkers
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0.26 1.00 3.00
Risk Ratio (95% CI)
Traffic injury prevention, use of rear seat belt
Traffic injury prevention, use of motorbike helmet
Traffic injury prevention, use of front seat belt
Smoking, physician cessation advice
Smoking, former
Smoking, current
Smoking, cessation attempt
Smoking ban, compliance in public places
Smoking ban, compliance at workplace
Smoking, abuse/dependence
Physical activity, sedentaty behaviour
Physical activity, partly active
Physical activity, active
Illicit drugs, abuse/dependence
Daily fruit & vegetables consuption, no portions
Daily fruit & vegetables consuption, 5+ portions
Daily fruit & vegetables consuption, 3-4 portions
Daily fruit & vegetables consuption, 1-2 portions
Alcohol, regular excessive consumption
Alcohol, past-30-day drinking
Alcohol, outside meals
Alcohol, abuse/dependence
0.99 [0.67, 1.47]
0.96 [0.88, 1.04]
1.04 [0.97, 1.12]
0.99 [0.72, 1.36]
0.67 [0.52, 0.86]
1.08 [0.89, 1.31]
0.72 [0.53, 0.97]
1.04 [0.99, 1.10]
1.05 [0.98, 1.13]
1.71 [1.25, 2.36]
2.01 [1.56, 2.60]
0.75 [0.63, 0.90]
0.77 [0.65, 0.91]
1.07 [0.60, 1.90]
0.56 [0.26, 1.20]
0.97 [0.68, 1.38]
1.23 [1.02, 1.49]
0.90 [0.79, 1.02]
0.66 [0.38, 1.16]
0.86 [0.77, 0.96]
0.91 [0.60, 1.38]
1.11 [0.73, 1.68]Geographical 24 1 50/543 34/409 - 0.6302
Temporal 19 1 83/947 27/281 - 0.6628
Temporal 19 1 501/947 173/281 - 0.0070
Temporal 19 1 38/945 17/280 - 0.1465
Temporal 19 1 447/955 148/283 - 0.0950
Temporal 19 1 375/955 90/283 - 0.0279
Temporal 19 1 114/955 35/283 - 0.8449
Temporal 19 1 19/955 10/283 - 0.1355
Geographical 24 1 27/543 19/409 - 0.8160
Temporal 19 1 301/943 113/271 - 0.0019
Temporal 19 1 278/943 106/271 - 0.0019
Temporal 19 1 364/943 52/271 - 1.0080e-07
Geographical 24 1 107/543 47/409 - 0.0009
Temporal 19 1 482/548 150/179 - 0.1843
Temporal 19 1 782/889 239/283 - 0.1509
Temporal 19 1 95/316 36/86 - 0.0309
Temporal 19 1 325/956 89/283 - 0.4299
Temporal 19 1 156/956 69/283 - 0.0017
Temporal 19 1 56/113 29/58 - 0.9562
Temporal 19 1 750/951 213/281 - 0.2927
Temporal 19 1 183/206 62/67 - 0.3377
Temporal 19 1 109/845 27/208 - 0.9750
Comparison
Follow-up
(months) Studies
Exposed
Events/Participants
Unexposed
Events/Participants I²
Effect
p-value
Lifestyle & prevention
Supplementary Materials 4. Full results of all earthquake effects
Page 24 of 50
0.62 200.00
Incidence Rate Ratio (95% CI)
Anti-psychotics, typical
Anti-psychotics
Anti-psychotics, Risperidone
Anti-psychotics, Quetiapine
Anti-psychotics, Promazine
Anti-psychotics, Olanzapine
Anti-psychotics, Levomeprazine
Anti-psychotics, Haloperidol
Anti-psychotics, Clozapine
Anti-psychotics, Clotiapine
Anti-psychotics, Chlorpromazine
Anti-psychotics, atypical
Anti-psychotics, Aripiprazole
Anti-psychotics, Amilsulpride
Anti-depressants, tryciclics
Anti-depressants
Anti-depressants, serotonin reuptake inhibitors
Anti-depressants, other
 1.01 [ 0.98,   1.05]
 1.06 [ 1.04,   1.08]
 1.41 [ 1.18,   1.68]
 1.35 [ 1.18,   1.54]
65.54 [24.41, 175.93]
 1.21 [ 1.04,   1.41]
 1.09 [ 0.83,   1.42]
 1.38 [ 1.22,   1.56]
 1.03 [ 0.79,   1.34]
 1.45 [ 1.07,   1.96]
 1.04 [ 0.85,   1.26]
 1.06 [ 1.04,   1.09]
 0.83 [ 0.63,   1.09]
 3.48 [ 2.70,   4.49]
 0.95 [ 0.94,   0.96]
 1.00 [ 0.99,   1.01]
 1.02 [ 1.01,   1.02]
 0.99 [ 0.98,   0.99]Temporal 11 1 194,732/275,590 215,030/300,818 - 0.0002
Temporal 11 1 518,236/275,590 556,427/300,818 - 1.3524e-17
Temporal 11 1 75,890/275,590 82,615/300,819 - 0.5931
Temporal 11 1 81,998/275,590 94,447/300,818 - 2.0293e-29
Temporal 1 1 268/25,054 77/25,068 - 4.9081e-22
Temporal 1 1 92/25,054 111/25,068 - 0.1844
Temporal 11 1 11,923/275,590 12,261/300,818 - 3.5421e-06
Temporal 1 1 203/25,054 196/25,068 - 0.7217
Temporal 1 1 103/25,054 71/25,068 - 0.0157
Temporal 1 1 111/25,054 108/25,068 - 0.8360
Temporal 1 1 596/25,054 433/25,068 - 3.9997e-07
Temporal 1 1 111/25,054 102/25,068 - 0.5348
Temporal 1 1 353/25,054 292/25,068 - 0.0161
Temporal 1 1 262/25,054 4/25,068 - 1.0227e-16
Temporal 1 1 508/25,054 376/25,068 - 9.3605e-06
Temporal 1 1 297/25,054 211/25,068 - 0.0001
Temporal 11 1 17,445/275,590 18,012/300,819 - 1.6512e-07
Temporal 11 1 6,950/275,590 7,481/300,818 - 0.4019
Comparison
Follow-up
(months) Studies
Exposed
Events/Person-years
Unexposed
Events/Person-years I²
Effect
p-value
Pharmachology (Incidence Rate Ratio)
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-20.00 0.00 20.00 40.00
Mean Difference (95% CI)
Pulse methylprednisolone, courses
Propylthiouracil
Prednisolone, initial dose
Haemodialisis adequacy (Kt/V)
Ccyclophosphamide, initial dose
Anti-diabetic drugs, insulin
1.40 [  0.74,  2.06]
0.00 [-11.50, 11.50]
8.70 [ -6.28, 23.68]
0.00 [ -0.14,  0.14]
0.80 [-19.17, 20.77]
0.01 [ -0.09,  0.11]U/kg/day Temporal 12 1 64 65 - 0.8393
mg/day Geographical 36 1 14 16 - 0.9374
- Temporal 2 1 25 25 - 1.0000
mg/day Geographical 36 1 14 16 - 0.2550
mg/day Temporal 2 1 76 76 - 1.0000
- Geographical 36 1 14 16 - 3.0812e-05
Unit Comparison
Follow-up
(months) Studies
Exposed
Participants
Unexposed
Participants I²
Effect
p-value
Pharmachology (Mean Difference)
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0.11 1.00 15.00
Risk Ratio (95% CI)
Thionamide
Iodine-131
Haemodialisis, emergency
Anti-hypertensive drugs
Anti-hypertensive drugs, calcium channel blockers
Anti-hypertensive drugs, angiotensin receptor blockers
Anti-hypertensive drugs, angiotensin-converting enzyme inhibitors
Anti-hypertensive drugs, angiotensin-converting enzyme inhibitors, or angiotensin receptor blockers, or calcium channel blockers with diuretics
Anti-hypertensive drugs, alpha-blocker
Anti-diabetic drugs
Anti-diabetic drugs, oral
Anti-diabetic drugs, oral and insulin
Anti-diabetic drugs, insulin, twice daily injections
Anti-diabetic drugs, insulin, twice daily injections, short and/or intermediate mixed
Anti-diabetic drugs, insulin, twice daily injections, rapid and intermediate mixed
Anti-diabetic drugs, insulin, multiple (four times) daily injections
Anti-diabetic drugs, insulin, multiple (four times) daily injectionss, rapid and long
Anti-diabetic drugs, insulin, multiple (four times) daily injections, short and/or intermediate
Anti-diabetic drugs, insulin, multiple (four times) daily injections, rapid and intermediate
Anti-diabetic drugs, insulin, continuous subcutaneous rapid infusion
1.02 [0.78,  1.32]
1.00 [0.74,  1.35]
3.43 [1.15, 10.22]
0.95 [0.80,  1.11]
1.00 [0.42,  2.36]
1.00 [0.44,  2.26]
0.36 [0.12,  1.12]
1.41 [0.84,  2.36]
1.01 [0.78,  1.31]
1.01 [0.93,  1.10]
0.99 [0.81,  1.22]
1.04 [0.82,  1.31]
1.02 [0.47,  2.17]
1.16 [0.45,  3.01]
0.76 [0.18,  3.27]
0.99 [0.77,  1.28]
1.08 [0.76,  1.53]
1.02 [0.15,  6.99]
0.68 [0.26,  1.79]
1.02 [0.49,  2.09]Temporal 12 1 12/64 12/65 - 0.9664
Temporal 12 1 6/64 9/65 - 0.4324
Temporal 12 1 2/64 2/65 - 0.9874
Temporal 12 1 33/64 31/65 - 0.6605
Temporal 12 1 41/64 42/65 - 0.9477
Temporal 12 1 3/64 4/65 - 0.7142
Temporal 12 1 8/64 7/65 - 0.7594
Temporal 12 1 11/64 11/65 - 0.9682
Temporal 6 1 87/222 84/222 - 0.7699
Temporal 6 1 99/222 100/222 - 0.9240
Temporal 6 1 186/222 184/222 - 0.7990
Temporal 6 1 77/222 76/222 - 0.9205
Temporal 6 1 31/222 22/222 - 0.1907
Temporal 6 1 4/222 11/222 - 0.0791
Temporal 6 1 11/222 11/222 - 1.0000
Temporal 6 1 10/222 10/222 - 1.0000
Temporal 6 1 123/222 130/222 - 0.5025
Geographical 36 1 9/14 3/16 - 0.0270
Temporal 2 1 54/145 54/145 - 1.0000
Temporal 2 1 61/128 60/128 - 0.9004
Comparison
Follow-up
(months) Studies
Exposed
Events/Participants
Unexposed
Events/Participants I²
Effect
p-value
Pharmachology (Risk Ratio)
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0.50 1.00 1.50
Risk Ratio (95% CI)
Pap test
Mammography
Colonoscopy
Cholesterol test
Blood pressure test
0.73 [0.54, 0.97]
1.13 [0.69, 1.84]
0.86 [0.52, 1.42]
1.00 [0.89, 1.12]
0.91 [0.84, 0.98]Temporal 19 1 672/956 219/283 - 0.0123
Temporal 19 1 539/957 160/283 - 0.9488
Temporal 19 1 51/370 17/106 - 0.5564
Temporal 19 1 58/184 14/50 - 0.6375
Temporal 19 1 113/405 40/104 - 0.0296
Comparison
Follow-up
(months) Studies
Exposed
Events/Participants
Unexposed
Events/Participants I²
Effect
p-value
Screening
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-30.00 -10.00 10.00
Mean Difference (95% CI)
Vineland Adaptive Behaviour Scales, Socialisation
Vineland Adaptive Behaviour Scales, Socialisation
Vineland Adaptive Behaviour Scales, Motor Skills
Vineland Adaptive Behaviour Scales, Motor Skills
Vineland Adaptive Behaviour Scales, Daily Living
Vineland Adaptive Behaviour Scales, Daily Living
Vineland Adaptive Behaviour Scales, Communication
Vineland Adaptive Behaviour Scales, Communication
Strengths and Difficulties Questionnaire, Total difficulties
Strengths and Difficulties Questionnaire, Prosocial score
Strengths and Difficulties Questionnaire, Peer problems score
Strengths and Difficulties Questionnaire, Hyperactivity score
Strengths and Difficulties Questionnaire, Emotional symptoms score
Strengths and Difficulties Questionnaire, Conduct problems score
Screen for Child Anxiety Related Emotional Disorders, Total score
Screen for Child Anxiety Related Emotional Disorders, Factor 5
Screen for Child Anxiety Related Emotional Disorders, Factor 4
Screen for Child Anxiety Related Emotional Disorders, Factor 3
Screen for Child Anxiety Related Emotional Disorders, Factor 2
Screen for Child Anxiety Related Emotional Disorders, Factor 1
Children’s Depression Inventory
-12.90 [-16.68,  -9.12]
-14.35 [-18.21, -10.49]
 -2.10 [ -6.36,   2.16]
-10.65 [-16.98,  -4.32]
-12.15 [-16.98,  -7.32]
-16.20 [-20.59, -11.81]
 -8.05 [-16.27,   0.17]
-10.10 [-17.50,  -2.70]
  0.21 [ -1.87,   2.29]
  0.26 [ -0.29,   0.81]
 -0.22 [ -0.77,   0.33]
 -0.03 [ -0.81,   0.75]
  0.20 [ -0.48,   0.88]
  0.01 [ -0.50,   0.52]
  2.46 [ -2.14,   7.06]
  0.17 [ -0.17,   0.51]
  0.18 [ -0.15,   0.51]
  0.33 [  0.02,   0.64]
 -0.17 [ -0.52,   0.18]
  0.00 [ -0.31,   0.31]
  2.92 [  0.78,   5.06]- Geographical 6 1 115 48 - 0.0075
- Geographical 6 1 115 48 - 1.0000
- Geographical 6 1 115 48 - 0.3368
- Geographical 6 1 115 48 - 0.0348
- Geographical 6 1 115 48 - 0.2895
- Geographical 6 1 115 48 - 0.3334
- Geographical 6 1 115 48 - 0.2949
- Geographical 6 1 115 36 - 0.9691
- Geographical 6 1 115 36 - 0.5654
- Geographical 6 1 115 36 - 0.9398
- Geographical 6 1 115 36 - 0.4325
- Geographical 6 1 115 36 - 0.3558
- Geographical 6 1 115 36 - 0.8434
- Geographical 12 1 18 18 - 0.0074
- Temporal 12 1 18 18 - 0.0548
- Geographical 12 1 18 18 - 4.6349e-13
- Temporal 12 1 18 18 - 8.1598e-07
- Geographical 12 1 18 18 - 0.0010
- Temporal 12 1 18 18 - 0.3337
- Geographical 12 1 18 18 - 3.3819e-13
- Temporal 12 1 18 18 - 2.2391e-11
Unit Comparison
Follow-up
(months) Studies
Exposed
Participants
Unexposed
Participants I²
Effect
p-value
Psychometric scales, Children
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-5.00 0.00 5.00 10.00
Mean Difference (95% CI)
MMPI-A, Social Discomfort
MMPI-A, School Problems
MMPI-A, Obsessiveness
MMPI-A, Low Self-Esteem
MMPI-A, Low Aspirations
MMPI-A, Health Concerns
MMPI-A, Family Problems
MMPI-A, Depression
MMPI-A, Cynism
MMPI-A, Conduct Problems
MMPI-A, Bizarre Mentation
MMPI-A, Anxiety
MMPI-A, Anger
MMPI-A, Alienation
MMPI-A, Adolescent-Negative Treatment Indicators
 4.12 [ 2.15, 6.08]
 3.02 [ 0.67, 5.37]
 4.27 [ 2.18, 6.36]
 1.30 [-0.69, 3.28]
 3.45 [ 1.10, 5.81]
 1.60 [-0.18, 3.38]
 3.31 [ 1.35, 5.28]
 5.09 [ 2.94, 7.24]
 2.01 [ 0.02, 4.01]
 1.74 [-0.43, 3.92]
 3.74 [ 1.26, 6.21]
 7.26 [ 5.17, 9.35]
 3.19 [ 1.29, 5.10]
 0.48 [-2.04, 2.99]
-0.68 [-3.22, 1.86]- Temporal 11 1 149 179 - 0.5994
- Temporal 11 1 149 179 - 0.7107
- Temporal 11 1 149 179 - 0.0010
- Temporal 11 1 149 179 - 8.9411e-12
- Temporal 11 1 149 179 - 0.0031
- Temporal 11 1 149 179 - 0.1164
- Temporal 11 1 149 179 - 0.0477
- Temporal 11 1 149 179 - 3.4729e-06
- Temporal 11 1 149 179 - 0.0010
- Temporal 11 1 149 179 - 0.0789
- Temporal 11 1 149 179 - 0.0041
- Temporal 11 1 149 179 - 0.2017
- Temporal 11 1 149 179 - 6.3193e-05
- Temporal 11 1 149 179 - 0.0118
- Temporal 11 1 149 179 - 3.9815e-05
Unit Comparison
Follow-up
(months) Studies
Exposed
Participants
Unexposed
Participants I²
Effect
p-value
Psychometric scales, Minnesota Multiphasic Personality Inventory-Adolescent
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-0.40 -0.20 0.00
Mean Difference (95% CI)
CAPE, Overall scores, Positive Dimension
CAPE, Overall scores, Negative Dimension
CAPE, Overall scores, Depressive Dimension
CAPE, Frequency, Positive Dimension
CAPE, Frequency, Negative Dimension
CAPE, Frequency, Depressive Dimension
CAPE, Distress, Positive Dimension
CAPE, Distress, Negative Dimension
CAPE, Distress, Depressive Dimension
-0.14 [-0.18, -0.10]
-0.09 [-0.14, -0.04]
-0.14 [-0.20, -0.08]
-0.09 [-0.13, -0.05]
-0.01 [-0.06,  0.04]
-0.07 [-0.12, -0.02]
-0.23 [-0.28, -0.18]
-0.25 [-0.32, -0.18]
-0.25 [-0.32, -0.18]SD change Temporal 10 1 419 1,057 - 2.2102e-11
SD change Temporal 10 1 419 1,057 - 7.2347e-14
SD change Temporal 10 1 419 1,057 - 6.1871e-18
SD change Temporal 10 1 419 1,057 - 0.0120
SD change Temporal 10 1 419 1,057 - 0.6967
SD change Temporal 10 1 419 1,057 - 1.1199e-05
SD change Temporal 10 1 419 1,057 - 2.2608e-06
SD change Temporal 10 1 419 1,057 - 0.0005
SD change Temporal 10 1 419 1,057 - 1.6345e-13
Unit Comparison
Follow-up
(months) Studies
Exposed
Participants
Unexposed
Participants I²
Effect
p-value
Psychometric scales, Community Assessment of Psychic Experiences
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-6.00 -2.00 2.00
Mean Difference (95% CI)
CSQ, Rational
CSQ, Emotional
CSQ, Detached
CSQ, Avoidance
-2.46 [-4.39, -0.53]
 0.19 [-1.93,  2.31]
-0.71 [-2.12,  0.70]
-2.87 [-5.05, -0.69]- Geographical 3 1 52 29 - 0.0097
- Geographical 3 1 52 29 - 0.3227
- Geographical 3 1 52 29 - 0.8604
- Geographical 3 1 52 29 - 0.0123
Unit Comparison
Follow-up
(months) Studies
Exposed
Participants
Unexposed
Participants I²
Effect
p-value
Psychometric scales, Coping Style Questionnaire
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-5.00 0.00 5.00 10.00
Mean Difference (95% CI)
CSS, Sum of social support
CSS, Someone willing to listen
CSS, Satisfaction with support
CSS, Receiving sympathy
CSS, Practical support
CSS, Feeling let down
CSS, Contact with others in similar situation
CSS, Ability to express oneself
5.53 [ 2.99, 8.07]
1.20 [ 0.38, 2.02]
0.05 [-0.62, 0.72]
0.35 [-0.44, 1.14]
0.20 [-0.60, 1.00]
0.71 [-0.10, 1.52]
2.75 [ 1.93, 3.57]
0.82 [-0.03, 1.67]- Geographical 3 1 52 29 - 0.0579
- Geographical 3 1 52 29 - 4.6594e-11
- Geographical 3 1 52 29 - 0.0845
- Geographical 3 1 52 29 - 0.6245
- Geographical 3 1 52 29 - 0.3849
- Geographical 3 1 52 29 - 0.8835
- Geographical 3 1 52 29 - 0.0041
- Geographical 3 1 52 29 - 1.9069e-05
Unit Comparison
Follow-up
(months) Studies
Exposed
Participants
Unexposed
Participants I²
Effect
p-value
Psychometric scales, Crisis Support Scale
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-0.50 0.00 0.50 1.00 1.50
Mean Difference (95% CI)
GHQ, Somatic Symptoms
GHQ, Social Dysfunction
GHQ, Sleep Disturbance or Anxiety
0.51 [ 0.09, 0.93]
1.11 [ 0.72, 1.50]
0.62 [-0.12, 1.36]- Geographical 2 2 314 554 88.4% 0.1026
- Geographical 2 1 157 277 - 1.7488e-08
- Geographical 2 1 157 277 - 0.0184
Unit Comparison
Follow-up
(months) Studies
Exposed
Participants
Unexposed
Participants I²
Effect
p-value
Psychometric scales, General Health Questionnaire
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0.00 2.00 4.00 6.00
Mean Difference (95% CI)
HTQ, Reexperiencing
HTQ, Avoidance
HTQ, Arousal
3.88 [2.63, 5.13]
1.87 [0.25, 3.49]
3.24 [1.89, 4.59]- Geographical 3 1 52 29 - 2.5243e-06
- Geographical 3 1 52 29 - 0.0236
- Geographical 3 1 52 29 - 1.1336e-09
Unit Comparison
Follow-up
(months) Studies
Exposed
Participants
Unexposed
Participants I²
Effect
p-value
Psychometric scales, Harvard Trauma Questionnaire
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-20.00 0.00 10.00
Mean Difference (95% CI)
HSS-MBI, Personal Accomplishment
HSS-MBI, Personal Accomplishment
HSS-MBI, Emotional Exhaustion
HSS-MBI, Emotional Exhaustion
HSS-MBI, Depersonalization
HSS-MBI, Depersonalization
-5.80 [-10.32, -1.28]
-4.90 [ -9.10, -0.70]
 5.80 [ -0.19, 11.79]
 6.20 [  1.22, 11.18]
 0.40 [ -1.70,  2.50]
 0.20 [ -1.57,  1.97]- Geographical 24 1 11 53 - 0.8244
- Temporal 24 1 11 11 - 0.7095
- Geographical 24 1 11 53 - 0.0146
- Temporal 24 1 11 11 - 0.0579
- Geographical 24 1 11 53 - 0.0222
- Temporal 24 1 11 11 - 0.0120
Unit Comparison
Follow-up
(months) Studies
Exposed
Participants
Unexposed
Participants I²
Effect
p-value
Psychometric scales, Human Services Survey - Maslach Burnout Inventory
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-4.00 0.00 4.00
Mean Difference (95% CI)
PNSS, Positive symptoms
PNSS, Negative symptoms
 2.72 [ 1.33, 4.10]
-0.46 [-2.10, 1.19]- Temporal 3 1 101 117 - 0.5872
- Temporal 3 1 101 117 - 0.0001
Unit Comparison
Follow-up
(months) Studies
Exposed
Participants
Unexposed
Participants I²
Effect
p-value
Psychometric scales, Positive and Negative Syndrome Scale
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-20.00 0.00 20.00 60.00
Mean Difference (95% CI)
POMS, Vigour-Activity score
POMS, Total Mood Disturbance score
POMS, Tension-Anxiety score
POMS, Fatigue-Inertia score
POMS, Depression-Dejection score
POMS, Confusion score
POMS, Anger-Hostility score
General Health Questionnaire score
-3.00 [-11.86,  5.86]
15.50 [ -9.65, 40.65]
 1.00 [ -7.32,  9.32]
 0.43 [ -9.32, 10.18]
-5.71 [-16.31,  4.89]
14.14 [  5.39, 22.89]
 2.64 [ -7.10, 12.38]
 2.15 [ -2.41,  6.71]- Temporal 3 1 14 15 - 0.3552
- Temporal 3 1 14 15 - 0.5951
- Temporal 3 1 14 15 - 0.0015
- Temporal 3 1 14 15 - 0.2912
- Temporal 3 1 14 15 - 0.9311
- Temporal 3 1 14 15 - 0.8137
- Temporal 3 1 14 15 - 0.2271
- Temporal 3 1 14 15 - 0.5071
Unit Comparison
Follow-up
(months) Studies
Exposed
Participants
Unexposed
Participants I²
Effect
p-value
Psychometric scales, Profile of Mood States
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-2.00 0.00 2.00
Mean Difference (95% CI)
RCFT, Recall
RCFT, Copy
0.19 [-1.77, 2.15]
0.04 [-0.72, 0.80]- Temporal 3 1 101 117 - 0.9128
- Temporal 3 1 101 117 - 0.8510
Unit Comparison
Follow-up
(months) Studies
Exposed
Participants
Unexposed
Participants I²
Effect
p-value
Psychometric scales, Rey Complex Figure Test
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-5.00 0.00 5.00 10.00
Mean Difference (95% CI)
STAI, Trait
STAI, Total
STAI, State
1.48 [-2.00,  4.96]
3.55 [-4.11, 11.21]
2.07 [-2.55,  6.69]- Geographical 6 1 115 36 - 0.3795
- Geographical 6 1 115 36 - 0.3634
- Geographical 6 1 115 36 - 0.4045
Unit Comparison
Follow-up
(months) Studies
Exposed
Participants
Unexposed
Participants I²
Effect
p-value
Psychometric scales, State and Trait Anxiety Inventory
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0.45 40.00
Risk Ratio (95% CI)
TALS-SR, Think about ending your life
TALS-SR, Intentionally scratch, cut, burn or hurt 11 yoursel
TALS-SR, Endorsed any suicidal screening items
TALS-SR, Attempt suicide
8.58 [1.96, 37.53]
1.93 [0.75,  4.92]
3.37 [1.52,  7.49]
2.45 [0.45, 13.32]Geographical 12 1 4/426 2/522 - 0.2993
Geographical 12 1 22/426 8/522 - 0.0029
Geographical 12 1 11/426 7/522 - 0.1714
Geographical 12 1 14/426 2/522 - 0.0043
Comparison
Follow-up
(months) Studies
Exposed
Events/Participants
Unexposed
Events/Participants I²
Effect
p-value
Psychometric scales, Trauma and Loss Spectrum-Self Report
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-2.00 0.00 2.00 4.00
Mean Difference (95% CI)
TSC, Somatization
TSC, Sleep problems
TSC, Interp. Prob.
TSC, Hostility
TSC, Dissociation
TSC, Depression
TSC, Anxiety
 0.42 [-1.05, 1.89]
 0.38 [-0.53, 1.29]
 0.37 [-0.84, 1.58]
 0.47 [-0.14, 1.08]
-0.12 [-1.29, 1.05]
 0.67 [-1.44, 2.78]
 0.18 [-1.41, 1.77]- Geographical 3 1 52 29 - 0.8239
- Geographical 3 1 52 29 - 0.5327
- Geographical 3 1 52 29 - 0.8403
- Geographical 3 1 52 29 - 0.1337
- Geographical 3 1 52 29 - 0.5499
- Geographical 3 1 52 29 - 0.4143
- Geographical 3 1 52 29 - 0.5744
Unit Comparison
Follow-up
(months) Studies
Exposed
Participants
Unexposed
Participants I²
Effect
p-value
Psychometric scales, Trauma Symptom Checklist
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-10.00 -5.00 0.00 5.00
Mean Difference (95% CI)
WMS-R, Delayed
IWMS-R, Immediate
-3.75 [-8.97, 1.46]
-3.81 [-9.70, 2.09]- Temporal 3 1 101 117 - 0.2055
- Temporal 3 1 101 117 - 0.1581
Unit Comparison
Follow-up
(months) Studies
Exposed
Participants
Unexposed
Participants I²
Effect
p-value
Psychometric scales, Wechsler Memory Scale-Revised
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-5.00 0.00 5.00 10.00
Mean Difference (95% CI)
WCST, Perseverative Errors
WCST, Categories
 0.98 [-3.26, 5.23]
-0.09 [-0.61, 0.43]- Temporal 3 1 101 117 - 0.7295
- Temporal 3 1 101 117 - 0.6498
Unit Comparison
Follow-up
(months) Studies
Exposed
Participants
Unexposed
Participants I²
Effect
p-value
Psychometric scales, Wisconsin Card Sorting Test
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-4.00 -2.00 0.00 2.00 4.00
Mean Difference (95% CI)
WAS, Self-worth
WAS, Self-control
WAS, Randomness
WAS, Luck
WAS, Control
WAS, Benevolence of World
 0.15 [-1.89, 2.19]
 0.00 [-1.76, 1.76]
-0.79 [-2.41, 0.83]
 1.39 [-0.44, 3.22]
 0.02 [-1.79, 1.83]
-0.64 [-2.49, 1.21]- Geographical 3 1 52 29 - 0.4975
- Geographical 3 1 52 29 - 0.9827
- Geographical 3 1 52 29 - 0.1362
- Geographical 3 1 52 29 - 0.3394
- Geographical 3 1 52 29 - 1.0000
- Geographical 3 1 52 29 - 0.8856
Unit Comparison
Follow-up
(months) Studies
Exposed
Participants
Unexposed
Participants I²
Effect
p-value
Psychometric scales, World Assumption Scale
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-1.50 -0.50 0.50
Mean Difference (95% CI)
WHO-QOL26, Social relationship
WHO-QOL26, Psychological functioning
WHO-QOL26, Physical functioning
WHO-QOL26, Global functioning
WHO-QOL26, Environmental functioning
-0.41 [-1.03, 0.21]
 0.01 [-0.42, 0.44]
-0.26 [-0.64, 0.12]
 0.07 [-0.45, 0.59]
-0.17 [-0.59, 0.25]- Temporal 3 1 14 15 - 0.4237
- Temporal 3 1 14 15 - 0.7906
- Temporal 3 1 14 15 - 0.1752
- Temporal 3 1 14 15 - 0.9639
- Temporal 3 1 14 15 - 0.1940
Unit Comparison
Follow-up
(months) Studies
Exposed
Participants
Unexposed
Participants I²
Effect
p-value
Psychometric scales, World Health Organization Quality of Life 26
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-10.00 -5.00 0.00 5.00
Mean Difference (95% CI)
WHO-SUBI, Positive score
WHO-SUBI, Negative score
-3.93 [-8.84,  0.98]
-5.22 [-9.65, -0.79]- Temporal 3 1 14 15 - 0.0210
- Temporal 3 1 14 15 - 0.1165
Unit Comparison
Follow-up
(months) Studies
Exposed
Participants
Unexposed
Participants I²
Effect
p-value
Psychometric scales, World Health Organization Subjective Well-being Inventory
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-5.00 0.00 5.00 10.00
Mean Difference (95% CI)
Visual attention (Continuous Performance Test)
Posttraumatic Stress Disorder Reaction Index
Pittsburgh Sleep Quality Index
Pittsburgh Sleep Quality Index
Pittsburgh Sleep Quality Index-Addendum
Patient Health Questionnaire-9
Generalized Anxiety Disorder-7
Early information processing (digit span)
Difficulty falling or remaining asleep, continuous
Depression Self-Rating Scale
Beck Depression Inventory
Acute Stress Disorder Scale
 0.74 [-2.13, 3.60]
 1.20 [-0.33, 2.73]
 1.82 [ 1.54, 2.10]
 1.89 [ 1.58, 2.19]
 3.41 [ 2.93, 3.89]
 2.79 [ 1.62, 3.96]
 2.70 [ 1.45, 3.94]
-0.32 [-2.33, 1.69]
 1.55 [ 1.45, 1.66]
 0.30 [-0.53, 1.13]
 3.91 [ 3.14, 4.68]
 3.05 [-0.36, 6.47]- Geographical 2 1 168 177 - 0.0799
- Geographical 24 1 665 486 - 2.4729e-23
- Geographical 3 1 1,685 252 - 0.4790
- Temporal 4 1 2,520 2,520 - 9.1795e-186
- Temporal 3 1 101 117 - 0.7528
- Geographical 2 1 168 177 - 2.2145e-05
- Geographical 2 1 168 177 - 3.0571e-06
- Geographical 24 1 665 486 - 7.6300e-44
- Geographical 24 1 665 486 - 3.9782e-34
- Temporal 24 1 665 754 - 3.1284e-37
- Geographical 3 1 1,685 252 - 0.1239
- Temporal 3 1 101 117 - 0.6136
Unit Comparison
Follow-up
(months) Studies
Exposed
Participants
Unexposed
Participants I²
Effect
p-value
Psychometric scales, Others (Mean Difference)
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1.00 5.50
Risk Ratio (95% CI)
Difficulty falling or remaining asleep, binary 6.02 [5.22, 6.95]Temporal 4 1 1,138/2,520 189/2,520 - 2.1372e-132
Comparison
Follow-up
(months) Studies
Exposed
Events/Participants
Unexposed
Events/Participants I²
Effect
p-value
Psychometric scales, Others (Risk Ratio)
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0.02 1.00 60.00
Risk Ratio (95% CI)
Superordinate Theme, Threat
Superordinate Theme, Passive-engagement
Superordinate Theme, Action-orientedt
Cognitions, Worry and concern
Cognitions, Self-soothing
Cognitions, Safety-seeking
Cognitions, Observing and explaining
Cognitions, More information
Cognitions, Excitement
Cognitions, Current threat
Cognitions, Confusion and shock or overwhelmed
Cognitions, Appeal to external forces
0.85 [0.55,  1.33]
1.58 [0.99,  2.53]
0.56 [0.26,  1.22]
0.73 [0.43,  1.24]
0.59 [0.21,  1.64]
0.53 [0.14,  2.01]
2.11 [0.85,  5.23]
1.05 [0.39,  2.81]
1.05 [0.02, 52.17]
1.76 [0.44,  7.01]
6.32 [0.79, 50.86]
0.53 [0.10,  2.76]Geographical 2 1 2/56 4/59 - 0.4485
Geographical 2 1 6/56 1/59 - 0.0831
Geographical 2 1 5/56 3/59 - 0.4252
Geographical 2 1 0/56 0/59 - 0.9795
Geographical 2 1 7/56 7/59 - 0.9170
Geographical 2 1 12/56 6/59 - 0.1081
Geographical 2 1 3/56 6/59 - 0.3473
Geographical 2 1 5/56 9/59 - 0.3082
Geographical 2 1 16/56 23/59 - 0.2441
Geographical 2 1 8/56 15/59 - 0.1456
Geographical 2 1 27/56 18/59 - 0.0569
Geographical 2 1 21/56 26/59 - 0.4760
Comparison
Follow-up
(months) Studies
Exposed
Events/Participants
Unexposed
Events/Participants I²
Effect
p-value
Cognitions and Superordinate Themes
Supplementary Materials 4. Full results of all earthquake effects
Page 50 of 50
Supplementary Materials 5. Description of the 39 earthquakes 
with magnitude ≥ 6.0 that occurred in high-income countries from 
1990 to 2012 and were not investigated by the studies included in 
this review 
 
Date Country Region Magnitudea N deathsa 
25 March 2012 Chile Maule 7.1 1 
17 April 2012 Chile Valparaiso 6.7 2 
20 May 2012 Italy Emilia, Northern Italy 6.0 7 
7 April 2011 Japan Near East coast of Honshu 7.1 3 
11 April 2011 Japan Eastern Honshu 6.6 7 
10 July 2009 Japan Near the south coast of Honshu 6.2 1 
8 June 2008 Greece Patras 6.4 2 
13 June 2008 Japan Eastern Honshu 6.9 13 
15 July 2008 Greece Dodecanese Islands 6.4 1 
23 July 2008 Japan Eastern Honshu 6.8 1 
21 April 2007 Chile Aisen 6.2 10 
16 July 2007 Japan Near the west coast of Honshu 6.6 9 
2 August 2007 Russia Tatar Strait 6.2 2 
14 November 2007 Chile Antofagasta 7.7 2 
12 December 2007 New Zealand Off east coast of the North Islan 6.6 1 
20 March 2005 Japan Kyushu 6.6 1 
27 September 2003 Russia Southwestern Siberia 7.3 3 
22 December 2003 USA San Simeon 6.6 2 
22 January 2002 Greece Crete 6.2 1 
6 September 2002 Italy Sicily 6.0 2 
24 March 2001 Japan Western Honshu 6.8 2 
24 July 2001 Chile Arica and Iquique 6.4 1 
1 July 2000 Japan Near the South Coast of Honshu 6.1 1 
30 January 1998 Chile Near coast of northern Chile 7.1 1 
29 July 1998 Chile Near the coast of central Chile 6.4 2 
26 September 1997 Italy Umbria e Marche, Central Italy 6.0 11 
15 October 1997 Chile Near Coast of Central Chile 7.1 8 
9 October 1996 Cyprus Cyprus Region 6.8 1 
15 June 1995 Greece Kozani-Grevena 6.5 26 
30 July 1995 Chile Near Coast of Northern Chile 8.0 3 
28 December 1994 Japan Off East Coast of Honshu 7.8 3 
15 January 1993 Japan Hokkaido 7.6 2 
12 July 1993 Japan Hokkaido 7.7 243 
21 September 1993 USA Oregon 6.0 2 
11 October 1993 Japan South of Honshu 6.9 1 
28 June 1992 USA Southern California 7.3 3 
29 April 1991 Georgia Georgia 7.0 114 
15 June 1991 Georgia Georgia 6.3 8 
21 December 1990 Greece Athens 6.1 1 
 
a Magnitude and number of deaths obtained from the United States Geological Survey 1990-2012 archive 1 
 
 
1.  U.S. Geological Survey. Earthquake Information by Year [Internet]. 2015 [cited 2015 Dec 18]. 
Available from: http://earthquake.usgs.gov/earthquakes/eqarchives/year/ 
 
